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GENERAL INTRODUCTION
Cholera is a human illness that is characterized by massive watery
diarrhea, leading to severe dehydration and hypovolemic shock if left untreated.
The characteristic symptom of the disease is the painless shedding of a
voluminous stool that resembles rice-water. Individuals can purge up to one liter
per hour, which is equivalent to 50Ib water loss within one day. Cholera is
endemic in Southeast Asia, Africa and Latin America where outbreaks are
associated with poverty and poor sanitation. Although this illness can be treated
simply by the replacement of fluid and electrolytes, it is associated with a 20-50%
mortality rate without medical treatment (149).
Cholera, which has a long history associated with humans, has had a
significant impact on science. There have been seven cholera pandemics since
1817, when the disease first spread from the Bay of Bengal along trade routes. In
earlier times, it was thought that cholera was spread like a fog, or “miasma”
coming from the river. However, during the third pandemic in 1854, which
reached the British Isles, the classic epidemiologic study of John Snow showed
that the disease was associated with ingestion of contaminated water (165). This
study was the fundamental basis for the field of epidemiology. Around this same
time, Filippo Pacini identified small comma-shaped particles, which he described
as Vibrios, associated with the intestinal epithelium of deceased cholera patients
in Florence, Italy (12). Pacini published this work in 1854 but it was almost
completely ignored by the scientific community, and not until 85 years later was
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he recognized as the discoverer of Vibrio cholerae, the causative organism of
cholera. During the fifth pandemic in 1883, Robert Koch isolated Vibrio cholerae
from a cholera patient in Calcutta, India, and was able to obtain a pure culture of
the bacteria (71). Although this bacterium failed to adhere to Koch’s postulate
that it causes disease in animals, Koch correctly interpreted the reason for this as
being the disease was human specific. Koch’s work on cholera was essential in
showing that a microorganism can cause disease, in addition to being a huge
step in establishing the field of microbiology.
Currently cholera outbreaks are still causing health disasters in many
different parts of the world. It has been estimated that there are 3–5 million
cholera cases and 100,000-120,000 deaths per year worldwide (34, 201). A
major outbreak occurred in 1994 in Goma, Zaire, which resulted in 70,000 cases
and 12,000 deaths (158). A more recent epidemic occurred in Zimbabwe. By July
2009 it was reported that there were more than 98,000 cholera cases and 4,000
deaths (1). It is important to realize that these figures might worsen in the near
future because cholera outbreaks are heightening. The rising sea levels and an
increase in water temperature are likely to dramatically increase cholera
outbreaks since coastal aquatic environments are a natural reservoir for V.
cholerae (44), the etiological agent of the disease. Thus studying and
understanding the pathogenesis and ecology of this organism should help in
developing strategies to reduce the severity and spreading of the disease.
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V. cholerae is a Gram-negative curved bacillus, and is highly motile having
a single polar sheathed flagellum. It is classified into serogroups based on its
lipopolysaccharide (LPS) O antigen, and more than 200 serogroups have been
identified to date (44, 149). Only serogroups O1 and O139 are responsible for
epidemic and pandemic cholera (14, 40, 131). Serogroup O1 can be further
divided into two biotypes, classical and El Tor, and this biotype classification is
based on differing biochemical properties and susceptibility to bacteriophages
(44). Each biotype is further subdivided into Ogawa, Inaba, and Hikojima
serotypes based on antigenic profile. Ogawa strains produce antigen A, B and a
small amount of C. Inaba strains produce antigen A and C, and Hikojima strains
produce small amount of all the three antigens (149). Although V. cholerae
isolates are available only from the 6th and 7th pandemics, it is thought that the
classical biotype was responsible for the first six pandemics while El Tor is
responsible for the current, seventh pandemic which began in Indonesia in 1961
(44, 149). Non-O1/ non O139 serogroups have also been associated with
diarrheal illness. However, these serogroups are not associated with endemic or
pandemic cholera and they cause illness that is self-limiting and is rarely lethal
(15).
V. cholerae is a natural inhabitant of coastal areas as it associates with
crustaceans such as copepods and shellfish, insect egg masses, and vertebrate
fish (17, 29, 60, 78, 153). Humans are the only known natural host in which V.
cholerae causes disease and an infection is acquired orally by ingesting
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contaminated food or water (44, 149). Once the bacteria enter the body, they
swim to the small intestine where they adhere to the epithelial cells and cause
diarrhea. By inducing diarrhea, V. cholerae are shed back into the environment in
the form of rice-water stool. The exact stimuli that induce virulence during
infection have not been identified. Once the bacteria reach the duodenum of the
small intestine, motility gene expression is down-regulated, virulence gene
expression is up-regulated and the disease is initiated. Later in infection,
virulence gene expression is down-regulated, motility gene expression is upregulated, and the bacteria escape the host. This “mucosal escape response
(133)” also requires expression of other genes. For example, proteases are
induced to help the bacteria detach from the epithelial surface while motility and
chemotaxis genes allow the bacteria to swim away, exiting the host and entering
back into the environment where V. cholerae completes its life cycle.
In aquatic environments, V. cholerae persist between epidemics and this
persistence is thought to be facilitated by biofilm formation and entering into a
viable but non-culturable state (VNC). V. cholerae are found free swimming in
planktonic form, or associated with marine organisms such as plants, green
algae, copepods, chironomid insects, and fish (17, 29, 60, 78, 80, 153). It has
been shown that V. cholerae form biofilms in the aquatic environment (4).
Bacteria within the biofilm are more resistant to several kinds of environmental
stress including antibiotics (156). When environmental conditions change, V.
cholerae sense these changes and modulate gene expression to adapt to these
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new conditions. Nutrient starvation and other stress responses that are found in
the aquatic environment are postulated to induce a VNC state form of V.
cholerae. These VNC V. cholerae cannot be recovered by standard culture
technique and so they are difficult to characterize. However, these seemingly
“dead” bacteria can cause infection and revert back to culturable bacteria when
grown with eukaryotic cells (5, 154).
There are two distinct acquired genetic elements that distinguish toxigenic
V. cholerae, i.e. strains that can cause cholera, from non-toxigenic strains: the
filamentous CTX bacteriophage (CTXΦ) (186), which encodes the cholera toxin
genes, and the Vibrio pathogenicity island (VPI) (91), which encodes the genes
that are required for production of toxin-coregulated structural pilus, accessory
colonization factor genes and several other genes having unknown roles in
pathogenesis. Non-toxigenic strains of V. cholerae can be converted into
toxigenic strains under appropriate conditions (186). Toxigenic strains can be
induced to produce extracellular CTXΦ particles. These phages can be
propagated into recipient non-toxigenic strains and integrate into their
chromosome to form stable lysogens. However, the propagation requires the
production of the toxin-coregulated pilus (TCP) by recipient cells as the phage
utilizes it as an entry receptor (186). Because TCP is produced during and
absolutely required for an infection, it seems that the human intestine is not the
only site that the bacteria exploit for infection, but also a site that augments the
conversion of non-toxigenic strains into toxigenic ones.
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Regulation of V. cholerae pathogenesis is complex and involves
numerous regulatory factors; the virulence regulon is commonly known as the
ToxR regulon due to the identification of ToxR as the first positive regulator of
virulence (126). The ToxR regulon includes the cholera toxin genes, the toxincoregulated pilus structural and assembly genes, the accessory colonization
factor genes, and other genes with undefined functions (43, 72, 90, 137, 177).
However, ToxR is not the direct activator of expression of most, if not all, of these
virulence genes. Instead, ToxR is required for production of ToxT (68), the direct
virulence activator, which will be discussed in more detail below.
For V. cholerae to cause cholera, two major virulence factors are
absolutely required: Cholera toxin (CT), which causes the diarrhea (45, 119), and
TCP, which is required for colonization of the human intestine (66). CT is the
most important V. cholerae virulence factor and is directly responsible for the
watery diarrhea that is the hallmark of cholera. CT is encoded by the ctxAB
genes on the filamentous lysogenic CTXΦ bacteriophage (186) and is a classical
AB5 toxin composed of pentameric B subunits and one enzymatic A subunit (52,
110). The B subunits recognize GM1 gangloside receptor on epithelial cells and
facilitate translocation of the A subunit in the cells (70, 185). Activity of the A
subunit requires processing to release the catalytic A1 component. The catalytic
A1 subunit modifies adenylate cyclase by adding an ADP-ribosyl group to keep it
locked in an active state and results in a greater than 100-fold increase in cellular
cAMP (53, 149). As a consequence, an alteration in ion transport is manifested
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by increasing chloride secretion and inhibition of sodium chloride absorption.
Osmotic balance results in massive amounts of water being secreted along with
the chloride ions, and the net result is a massive outpouring of fluid into the small
intestine causing the watery diarrhea (45). In addition, CT inhibits water
absorption by the colon, which also increases the severity of the disease (166).
The secreted fluid is characterized by high amounts of sodium, chloride,
potassium, bicarbonate and more importantly infectious V. cholerae (127). These
secreted fluids could then get released back into the environment where water
sources become contaminated. To make matters worse, the V. cholerae in ricewater stool are hyperinfectious; greater than 106 bacteria are required for an
initial infection, but once the V. cholerae have passed through a host, the
infectious dose is lowered to under 100 bacteria (21, 132, 199). The end result is
a quick spreading of V. cholerae within the population and an epidemic is
initiated.
The TCP type IV pilus is the other virulence factor that is absolutely
required to be expressed by V .cholerae in order to colonize the human intestine
and cause disease (66). It is termed “toxin co-regulated pilus” because its
expression occurs under the same conditions as those of the cholera toxin. The
TCP is composed of 5-6nm filaments containing a bundle of the TcpA pilin
subunit (59). Production of the pilus by V. cholerae leads to agglutination of the
cells. This auto-agglutination phenotype also provides a simple way to determine
whether the TCP is produced in bacteria grown in the laboratory. The major
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function of the TCP is to aid the overall colonization of the intestinal epithelial
lining. A tcpA mutant strain of V. cholerae neither colonizes the intestine of
human volunteers nor does it colonize the intestine of the infant mouse model
(66, 179). The mechanism by which the TCP promotes intestinal colonization is
not clear. However, in vitro and in vivo data suggest that it occurs through the
formation of microcolonies via pilus-pilus contacts between individual bacteria to
enhance overall colonization (89).
Although the pilus is a polymer of repeating subunits of one protein
(TcpA), several other genes are involved in the biogenesis of the pilus structure.
The tcpB, tcpQ, tcpC, tcpR, tcpD, tcpS, tcpT, tcpE, tcpF and the tcpJ genes are
all encoded within one operon termed the tcp operon (44) (Fig. 1). These genes
are located downstream of and in the same orientation as tcpA (79). They are
transcribed along with tcpA as a long transcript to promote the assembly of the
TCP structure on the surface of the bacteria. Transposon insertions that disrupt
tcpB, tcpC, tcpD, tcpE, or tcpF prevent assembly of a functional pilus on the
resulting bacterial surfaces, despite the fact that the TcpA pilin is still expressed
(16). The functions of these pilus biogenesis genes are poorly understood. TcpB
has a pilin-like prepeptide sequence and has been proposed to regulate pilus
length and/or function as a pilus anchor (175). TcpT possesses a putative ATPbinding domain (135), which might function as an engine to drive the pilus
translocation complex. TcpF is a soluble factor that is secreted by V. cholerae
and is important for bacterial colonization of the intestinal epithelial cells (98,

9

128). TcpJ is the best-described protein, encodes a leader peptidase that is
utilized to process the TcpA protein during secretion (87).
Expression of a collection of other genes carried on the VPI is also coregulated with CT and TCP. These include the acfABCD genes, which encode
the ACF, as well as tagA, aldA, and tcpI (39, 43, 61, 136, 137, 152, 190, 192).
The functions of these genes and their requirements for inducing disease are not
understood. However, deletion of any of the acf genes results in alteration of the
swarm motility, a phenotype that is associated with altered chemotaxis (42, 74).
In addition, based on protein alignments, AcfB and TcpI showed a significant
relationship with other enteric methyl-accepting chemotaxis proteins (26, 42, 62).
Collectively, V. cholerae may utilize these accessory genes to sense
chemoattractants that are found in the small intestine milieu to guide the bacteria
to the appropriate niche. tagA encodes a putative lipoprotein of unknown function
(61), and aldA encodes an aldehyde dehydrogenase that has an unknown role in
pathogenesis (136).
Aside from the virulence factors that are acquired by the two separated
mobile genetic elements, motility and chemotaxis genes are found in all V.
cholerae strains and play an important role in establishing an infection. V.
cholerae is highly motile via a single polar flagellum. There are conflicting results
regarding the requirement of motility for virulence (47-49, 146, 178, 194, 195).
This is the case especially when comparing different animal models and also
when comparing the classical versus the El Tor biotype. However, defined non-
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motile mutants of the El Tor biotype are attenuated in the infant mouse model as
several labs have demonstrated (20, 102, 159). The most convincing evidence to
argue that motility is important in infection come from vaccine trials. Liveattenuated V. cholerae vaccine produces side effects such as nausea, cramps
and diarrhea, while non- motile variants do not (31, 88, 120). These differences
were further linked to the ability of V. cholerae to reach the epithelial surfaces. In
addition, there is an inverse relationship between motility and virulence gene
expression. Hyper-swarming motile bacterial strains produce lower levels of TCP
and CT, while non-swarming motile bacteria produce a larger amount of TCP and
CT when compared to the wild type parent strain (49, 63, 64). Thus the current
favored model is that motility allows the bacteria to penetrate the mucus layer to
reach the epithelial cells, which is important for colonization and inducing
disease.
Chemotaxis genes have also been shown to be involved in the
pathogenesis of V. cholerae. The genome of V. cholerae encodes three different
general chemotaxis operons. However, only one of them is required for
chemotaxis and the functions of the other two are unknown (54). Chemotaxis
functions to direct movement of the bacteria in certain directions. This is
achieved by changing the direction of flagellar rotation from the default
counterclockwise (CCW) to clockwise (CW) direction. The CCW rotation propels
the cells forward by smooth swimming in one direction while CW rotation causes
the cells to tumble to change direction. CW-biased mutants have defects in net
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movement and are attenuated for infection (20). However, mutants with a CCWbias out-compete wild type V. cholerae during an infection (20). This competitive
dominance correlates with increased infectivity. Additional analysis revealed that
this CCW-biased mutant is able to colonize the entire mouse intestine, whereas
wild type V. cholerae preferentially colonize the distal end of the infant mouse
intestine (20). This may suggest that both motility and chemotaxis are tightly
regulated to direct V. cholerae to a localized niche during an infection.
Regulation of V. cholerae virulence determinants requires a complex
cascade of transcriptional events that involves numerous regulators. A schematic
of virulence induction is shown in Fig. 2. ToxT is the major transcriptional
activator that directly and positively induces expression of the vast majority of
virulence genes including those that encode the major virulence factors CT and
TCP (75, 190-192, 197, 198). Expression of toxT is induced by two membrane
dimers, ToxR/ToxS and TcpP/TcpH (39, 65, 67, 100). While the toxRS operon is
thought to be constitutively active, transcription of the tcpPH operon requires
cooperation between two other transcription activators, AphA and AphB (94,
160). Other regulatory circuits that affect AphA induction include quorum sensing
and small regulatory RNAs, which work through the master regulator quorum
sensing regulator, HapR (97, 124).
ToxT is an AraC/XylS family protein (68) that directly activates
transcription of the virulence genes of V. cholerae. ToxT positively activates
transcription of several operons including tcp, ctx, and acf. It also activates
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transcription of genes encoding a putative lipoprotein (tagA), aldehyde
dehydrogenase (aldA) and methyl-accepting chemotaxis protein (tcpI) (75, 190192, 197, 198). As previously mentioned, the functions of some of these genes in
pathogenesis are well characterized while the functions of others are unknown.
The 276 amino acid long ToxT protein is separated into two domains: amino
acids 1-160 comprise the N-terminal domain (NTD), whereas amino acids 170276 comprise the C-terminal domain (CTD). A linker (amino acids 161-169)
further connects the two domains (111). The ToxT CTD shares the AraC/XylS
family sequence homology and contains two helix-turn-helix motifs that are
utilized for DNA binding. The NTD does not share significant sequence similarity
with any protein in the database and its role is hypothesized to be for
dimerization and/or for interacting with effectors that modulate ToxT activity.
However, the crystal structures of ToxT protein and the AraC protein NTD
indicate that the ToxT NTD and the AraC NTD share some structural similarity
despite having only 11% amino acid identity (111). The AraC NTD is required for
dimerization and binding to its effector, arabinose (151). It has been proposed
that bile or the unsaturated fatty acids (UFA) present in bile are natural effectors
of ToxT. Bile and UFA have been shown to inhibit ToxT activity and the overall
growth of V. cholerae (57, 76, 152). Mutational analysis demonstrated that bile
might interact with the N-terminal domain of ToxT, as a ToxT mutant somewhat
resistant to bile was isolated that had a single amino acid change at residue 107
(141). Furthermore, the crystal structure of ToxT contained a buried 16-carbon
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UFA, cis-palmitoleate, which inhibits the activity of ToxT and may be a minor
component of crude bile (111). Virstatin, a synthetic compound that was found to
reduce ctxAB expression, also likely interacts with ToxT in the same region as
bile; a L114F mutation in ToxT makes ToxT resistant to virstatin (77, 155). This
suggests that this region of the NTD is important for controlling ToxT activity.
Although the activities of ToxR/S and TcpP/H are required for ToxT
production, evidence of ToxT auto-regulation also exists. The genetic
organization of the tcp operon is shown in Fig. 1; the toxT gene is located within
this tcp operon between tcpF and tcpJ. Transposon insertions in the region
between tcpA and tcpF cause a polar effect on ToxT activity as determined by
measuring CT production and expression of a tcpA-lacZ fusion (16). Further
analysis of toxT transcripts using primer extension revealed the presence of
transcripts that originated from two different promoters. Short transcripts
correspond to product that depends on the toxT promoter and long transcripts
correspond to tcpA promoter activity (67, 197). Transcription from the tcpA
promoter depends on the activity of ToxT and the long toxT transcripts depend
on the tcpA promoter, suggesting a model in which ToxT positively activates
more of itself through an auto-regulatory loop that is initiated from the tcpA
promoter.
ToxT activates the transcription of virulence gene promoters by binding to
degenerate thirteen base-pair DNA sequences termed toxboxes (191) (Fig. 3).
These toxboxes are organized differently within each promoter. For example,
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within the tcpA promoter there are two toxboxes that are organized as a direct
repeat, while between the divergently transcribed acfA and acfD genes the two
toxboxes are organized as an inverted repeat. Furthermore, within the aldA
promoter there is only a single toxbox, while the ctxAB promoter contains a
series of half toxboxes that are oriented as direct repeats. Although the toxbox
configuration and spacings are different within each promoter, all toxboxes are
located upstream of the core -35 sequence. This is consistent with class I
promoter architecture and suggests that ToxT directly interacts with RNA
polymerase α subunits to induce transcription (19). Mutational analysis of toxbox
spacings revealed that ToxT binds as a monomer to each toxbox and
dimerization is not required for DNA binding (11, 190, 191). However,
dimerization might be required to attract RNA polymerase and induce gene
expression. It has been proposed that virstatin acts to inhibit ToxT activity by
inhibiting dimerization; however, currently the evidence for this model is not
compelling. The difference in the architecture of the toxboxes may suggest a
unique interaction between ToxT and RNA polymerase at each promoter, which
dictates the strength of that promoter.
The ToxR/ToxS and the TcpP/TcpH dimers act in conjunction to control
the activation of toxT transcription (39, 65, 67, 100). The toxR gene is not linked
to the two acquired genetic elements, CTXΦ and VPI. ToxR is found in all V.
cholerae strains as well as other Vibrio species and was discovered based on its
ability to activate expression of a ctxAB::lacZ fusion construct in E. coli (126).
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ToxR is a 32kDa integral membrane protein that is localized to the inner
membrane and contains a cytoplasmic DNA binding domain, a transmembrane
domain, and a periplasmic domain. Its dimerization partner protein, ToxS, which
is also an integral membrane protein, enhances ToxR activity (37, 41, 138).
Current models suggest that ToxS functions to facilitate assembly and to stabilize
ToxR. The ToxR/ToxS dimer also regulates the expression of other genes such
as those encoding outer membrane porins (Omp). ToxR/S positively activates
ompU transcription while repressing ompT transcription (33, 106). These outer
membrane porins have been shown to protect the bacteria against bile that is
secreted into the small intestine (142).
The TcpP/TcpH dimer is also required for activation of the toxT promoter
(65, 100). Like ToxR, TcpP is an integral membrane protein that is localized to
the inner membrane and contains a cytoplasmic DNA binding domain, a
transmembrane domain, and a periplasmic domain. It also has a dimerization
partner, TcpH that functions to stabilize TcpP and protect it from proteolytic
degradation (8, 23). Utilizing the cytoplasmic DNA binding motifs, ToxR and
TcpP bind to the toxT promoter and positively activate the transcription of toxT
(65, 100). The binding sites for ToxR and TcpP proteins within the toxT
promoters are located in close proximity; ToxR binding sites are located between
-104 to -68 while the TcpP binding sites are located between -54 and -32 relative
to the start of transcription. Interestingly, overproduction of TcpP/TcpH
overcomes the ToxR/ToxS requirement and can alone activate the toxT promoter
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(100). These data may suggest that the TcpP/TcpH dimer is essential to activate
the toxT promoter and the ToxR/ToxS dimer functions to enhance this activation.
Additional regulators tightly regulate the tcpPH promoter, while the toxRS
is constitutively active under several growth conditions. AphA and AphB
cooperatively activate the tcpPH promoter (94, 160). AphA shares sequence
homology with the PadR repressor, which regulates expression of genes
involved in the detoxification of phenolic acids (6). AphB is a member of LysR
family of transcriptional regulators that acts synergistically with AphA to activate
transcription of the tcpPH promoter (94). The binding sites of AphA and AphB
within the tcpPH promoter overlap. AphA binds to a region between -101 and -71
while AphB binds to a region between -78 and -43 relative to the start of
transcription (96). The regulation of AphB is not yet defined. However,
expression of AphA is controlled by the master quorum sensing regulator, HapR
protein (97).
Besides controlling tcpP and tcpH induction, AphA and AphB have
additional roles in V. cholerae. AphA represses expression of genes involved in
the biosynthesis of acetoin from pyruvic acid (92). Shutting off this metabolic
pathway increases the accumulation of organic acid when the bacteria are grown
on excess glucose or carbohydrate. Because V. cholerae are sensitive to acidic
pH, increasing organic acids in the culture medium will lower the pH and reduce
cell viability. On the other hand, recent microarray analysis has identified five
genes (cadC, VC0770, clc, nhaB and cah) besides tcpP and tcpH that are
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activated by AphB (93). The cadC gene is the best characterized of these (181).
CadC is a transcriptional activator that plays a role in acid tolerance. CadC
protein activates the cadBA promoter, which encodes the lysine/cadaverine
antiporter and lysine decarboxylase respectively. These genes function to induce
the synthesis and excretion of cadaverine to buffer the external acidic
environment. It seems that AphB counteracts the activity of AphA to allow the
cells to tolerate any environmental acidification. AphB was also recently found to
have increased activity in the presence of low pH and anaerobic growth
conditions (93).
Expression of AphA is controlled by the quorum sensing master regulator
HapR (97). HapR shuts off expression of AphA by binding to the aphA promoter
and repressing transcription (97). As a result, the accumulated levels of AphA are
reduced and become insufficient to activate the tcpPH promoter. In addition to
virulence, HapR plays a central role in regulating other cellular processes
including biofilm formation and protease production. It represses the vps operon,
which prevents production of the exopolysaccharide involved in building a biofilm
nest (200). HapR also induces expression of HapA, a secreated hemagglutinin
and protease that functions in detaching the bacteria off epithelial cells during
host escape (46, 85).
The action of HapR is controlled by several quorum sensing cascades and
small regulatory RNA molecules. Quorum sensing is a process of cell-cell
communication that allows the bacteria to respond as a group to chemical signals
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and modulate their gene expression (123). V. cholerae has at least three
systems of signaling to control the level of hapR (104) (Fig. 4). The first system
involves the auto-inducer CAI-1 and the sensor kinase CqsS. The second system
involves the auto-inducer AI-2 and the LuxPQ receptor complex. In the presence
of low concentration of CAI-1 and AI-2 at low cell density, a phosphorelay
mechanism is initiated that leads to transfer of a phosphate group to LuxO
resulting in activation. LuxO in turn activates the production of four regulatory
sRNAs termed Qrr1-4, and, together with the chaperone Hfq protein these RNAs
destabilize hapR mRNA (105). The third quorum- sensing system, which involves
the two components VarSA, activates expression of three sRNAs (CsrBCD) to
inhibit the activity of the global posttranscriptional regulator CsrA. This also leads
to activation of LuxO through an unknown mechanism (104).
Other regulators that affect virulence gene expression levels, which
include the catabolic activator cAMP-CAP, the histone-like protein H-NS, and the
EAL/GGDEF proteins that regulate cellular concentrations of the secondary
messenger cyclic diguanylate, have been demonstrated to repress virulence
induction. The catabolic activator cAMP-CAP represses tcpPH transcription (96).
H-NS, which is a histone-like DNA binding protein that also acts as a major
transcriptional repressor, represses several other V. cholerae virulence genes
including ctxAB and toxT (134), and an increase in c-di-GMP concentrations
lowers accumulation of toxT mRNA via a mechanism that is not yet clear (180).
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cAMP-CRP negatively affects regulation of virulence gene expression by
repressing the tcpPH promoter (96). cAMP-CRP is a catabolic activator that
plays a major role in cellular metabolism by regulating the utilization of carbon
sources. Deletion of the crp gene in both the classical and the El Tor biotypes
causes virulence de-repression and increased levels of TCP and CT production
under non-permissive growth conditions (161). Despite the presence of potential
cAMP-CRP binding sites in the tcpA promoter, electrophoretic mobility shift
analysis (EMSA) failed to prove that purified functional CRP could occupy the
tcpA, toxT, or ctxAB promoters. Further analysis revealed that the crp deletion
strain increased tcpPH promoter activity, a step before toxT activation in the
regulatory cascade. In addition, cAMP-CRP binds to a region between -98 and 75 of the tcpPH promoter relative to the start of transcription (96). This region
overlaps the sites where the two activators AphA and AphB recognize and bind
to activate transcription. Thus it seems that cAMP-CRP competes with these
activators to turn off further activation and affects overall virulence induction.
H-NS is a global repressor, which silences virulence gene expression of V.
cholerae at multiple levels (134). H-NS has been implicated in transcriptional
repression of foreign genes that are acquired by horizontal transfer and this is
true for V. cholerae as well. It has been demonstrated that H-NS has the ability to
repress transcription from the tcpA, toxT, and the ctxAB promoters (134). H-NS is
a small protein that is encoded by the vicH gene on the large V. cholerae
chromosome. A vicH deletion strain de-represses virulence and produces higher
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levels of CT and TCP compared to wild type parent strains under non-permissive
pH growth conditions (134). The vicH mutant also produces higher levels of
β−galactosidase from toxT-lacZ and ctx-lacZ reporter constructs when grown
under many different conditions (169).
Although H-NS silences the tcpA, toxT and the ctxAB promoters, the
mechanism by which it does so is poorly understood. There are several
mechanisms that describe how H-NS represses transcription. However, they all
involve direct binding of H-NS to the promoter (169). The DNA binding
sequences that are usually occupied by H-NS are rich in A + T nucleotides. The
toxT, tcpA, and ctxAB promoter regions all possess A + T rich sequence, but the
H-NS binding sites within these promoters have yet to be determined.
Furthermore, there is conflicting data regarding tcpA repression by H-NS. If H-NS
repression of tcpA occurs, it is less dramatic than that of toxT and the ctxAB
(134). Repressing the toxT promoter would affect the level of ToxT protein and
so it would indirectly affect the transcription of the tcpA and the ctxAB promoters.
Signaling by the cytoplasmic secondary messenger cyclic diguanylate (cdi-GMP) also modulates virulence gene expression. c-di-GMP is used by most
bacteria to regulate numerous cellular processes including virulence (174). The
intracellular concentration of c-di-GMP is controlled by its total synthesis and
degradation. It is synthesized from two GTP molecules by enzymes that harbor
GGDEF domains and is hydrolyzed by enzymes that contain EAL domains into
linear pGpG, and then into two GMPs by enzymes that contain a HD-GYP
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domain (174). The genome of V. cholerae encodes 31 GGDEF, 22 EAL, 9 HDGYP, and 9 GGDEF-EAL proteins which indicate the complex regulation of c-diGMP cytoplasmic concentration. However, in classical biotype V. cholerae,
increasing and decreasing cytoplasmic c-di-GMP concentration is achieved by
deletion or over-production, respectively, of the response regulator vieA (180).
Increasing intracellular c-di-GMP causes a defect in colonizing the infant mouse
gut due to decreased CT production. Further analysis shows that increasing
cytoplasmic c-di-GMP concentration affects transcription of toxT, but does not
affect the transcription of tcpP or toxR (180). These results suggest that
increasing cytoplasmic c-di-GMP may affect the activity of TcpP and ToxR to
activate the toxT promoter, or the ability of ToxT to amplify more of itself from the
tcpA promoter.
In vivo environmental signals that are sensed by V. cholerae and induce
its virulence determinants are not known. However, in vitro studies led to the
discovery of a variety of physical and chemical environmental signals that the
bacteria sense to modulate virulence regulation. Culturing the bacteria under
specific pH, temperature, ion concentrations, carbon dioxide level and/or in the
presence of certain amino acids (asparagine, glutamate, serine, and arginine)
induces virulence (83, 125). This virulence induction is inhibited by the addition to
growth media of bile or bile components, which are also present in the human
small intestine where V. cholerae colonize (28, 57, 152). These in vitro
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environmental signals might differ from those in vivo, but could mimic what
occurs during the course of infection to regulate virulence expression.
Maximal virulence induction in vitro for the two biotypes of V. cholerae
requires different sets of growth conditions. In the classical biotype, maximal
virulence induction requires growing the bacteria in LB at pH 6.5 and 30º C. This
was termed ToxR-inducing conditions due to the significant role of the ToxR
protein in virulence induction. In contrast, minimal virulence induction results
when the cells are cultured in LB at pH 8.5 and 37º C (ToxR-repressing
conditions) (125). In the El Tor biotype, virulence induction occurs when growing
the bacteria under biphasic conditions termed AKI (82, 83). During the first
phase, the bacteria are cultured for several hours statically in AKI medium which
contains 1.5% peptone, 0.3% yeast extract, 0.5% NaCl, and 0.3% sodium
bicarbonate. During the second phase, an aliquot from the first phase is shifted to
vigorous aeration for another several hours. Under virulence inducing conditions,
both AphA and AphB induce TcpP/H expression and in conjunction with ToxR/S
dimer, toxT transcription is activated. Once ToxT protein is expressed, it
positively activates its own expression along with the tcp operon and other
various virulence factors including CT (117).
The difference between the two biotypes in growth condition requirements
that lead to virulence induction is due to differential transcription of the tcpPH
operon. Both the classical and the El Tor strains of V. cholerae express their
virulence factors under AKI conditions. However, the El Tor biotype does not
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express these genes under classical ToxR-inducing conditions (low pH and
temperature) (38, 129). Further analyses of virulence induction demonstrated
that the toxT and tcpPH transcripts are absent in the El Tor biotype but are
present in the classical biotype when culturing under classical ToxR-inducing
conditions. In addition, overexpression of ToxT or TcpPH under low pH and
temperature in the El Tor biotype results in restoration of virulence induction
(129). Complementation studies showed that toxT and tcpPH from one biotype
restored virulence expression in the corresponding alternate biotype deletion
strain (38, 129). These results suggest that the difference in virulence induction
between the two biotypes depends on activation of the tcpPH promoter, and this
could be differentially regulated either by trans-acting elements, cis-acting
elements, or both. AphA and AphB, which are the cis-acting activators of the
tcpPH promoter, are expressed at the same level in both biotypes under different
conditions (93, 160). Over-expression of AphA or AphB restores tcpPH induction
by El Tor under low pH and temperature, which suggests the difference in amino
acid sequence of these activators between the biotypes can’t account for this
non-induction phenotype. Instead, the tcpPH promoter DNA sequence slightly
differs between the biotypes; this difference could affect the binding of either
transcription activators or repressors that have been shown to bind to this region
under certain growth conditions. One major change occurs in the binding site of
AphB at the position of –65 relative to the start of transcription. Change from an
A to a G (classical to El Tor) disrupts a dyad symmetry and reduces tcpPH
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expression (95). Other changes are at the –87 and –86 positions within the
binding sites of AphA and cAMP-CRP. At these positions, the classical biotype
has a G and a C, while the El Tor has a T and an A, respectively. The
significance of these changes to differences in virulence induction has not yet
been characterized.
Alteration of pH, growth media, and temperature under ToxR inducing and
repressing conditions for the classical biotype has also been characterized and
acts to influence virulence induction at multiple levels. The expression and the
activity of AphA and AphB are reduced when grown at high pH and temperature
(93, 94, 160). This causes lower tcpPH expression and leads to lower toxT
induction and lower virulence as a whole. However, constitutive expression of
TcpPH

or ToxT

under ToxR-repressing

conditions

increases

virulence

expression, but the amount of virulence induction is still at a minimum when
compared to ToxR-inducing conditions (129). These results suggest additional
regulation occurs to control the activity of TcpP and ToxT posttranscriptionally.
Although ToxT regulation at the posttranscriptional level has not been
characterized (but it will be explored later in this dissertation), the level of TcpP is
shown to be regulated by proteolysis (8, 23, 116). TcpP degradation occurs
under ToxR-repressing conditions and is controlled by at least two sequential
steps with different proteases (116). Initially, TcpP is cleaved by an unknown
protease, and during the second step it is further degraded by YaeL protease.
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Controlling the level of TcpP through expression and degradation processes
could be an essential checkpoint to turn on and off the virulence cascade.
In vitro virulence growth conditions have been extensively studied and
most of the regulators that are involved in the virulence cascade were discovered
through these studies. However, in vivo studies have shown that virulence
regulation during infection might differ from in vitro conditions (103). First,
activation of ctxA in vitro requires both ToxR/ToxS and TcpP/TcpH dimers,
whereas in vivo activation requires only the ToxR/ToxS dimer (not the
TcpP/TcpH dimer) (103). Activation of ctxA, though, still occurs in a ToxTdependent manner. This suggests that the discrepancy between in vivo and in
vitro regulation occurs during the initial activation of the toxT promoter. Secondly,
analysis of the temporal and spatial expression patterns of tcpA and ctxA
revealed a difference in expression during infection versus during in vitro growth
(103). During infection, tcpA transcription occurs in two separate peaks while
ctxA occurs during the second peak of tcpA expression. In contrast, during in
vitro growth, expression patterns of these genes occur simultaneously in a toxTdependent manner (25, 36, 39, 197, 198). Lastly, in vivo TCP production is
required to produce maximum tcpA and ctxA promoter activity while this
requirement is absent during in vitro conditions. An in-frame tcpA deletion strain
produces lower tcpA and ctxA activity in vivo when compared to in vitro
conditions (103). Collectively, these results may suggest that the bacteria sense
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additional signals during infection to promote maximum virulence induction and
this requires production of TCP.
In summary, V. cholerae has evolved to utilize a complex array of gene
regulation to induce a devastating pandemic disease. Understanding at the
molecular level the mechanisms for how this pathogen induces virulence to
cause illness could identify new therapeutic targets to disrupt this virulence
regulation in cholera patients during outbreaks.
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FIG. 1. Genetic map of V.cholerae pathogenicity island (VPI).
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FIG. 2. The virulence regulatory network of V.cholerae.
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FIG. 3. The organization of toxboxes within ToxT activating gene promoters.
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FIG. 4. Quorum sensing systems and the small RNA molecules of V.cholerae
that regulate HapR expression.
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CHAPTER ONE
Bicarbonate Induces Vibrio cholerae Virulence Gene Expression by Enhancing
ToxT Activity
ABSTRACT
Vibrio cholerae is a gram-negative bacterium that is the causative agent of
cholera, a severe diarrheal illness. The two biotypes of V. cholerae O1 capable of
causing cholera, classical and El Tor, require different in vitro growth conditions
for induction of virulence gene expression. Growth under the inducing conditions
or infection of a host initiates a complex regulatory cascade that results in
production of ToxT, a regulatory protein that directly activates transcription of the
genes encoding cholera toxin (CT), toxin-coregulated pilus (TCP), and other
virulence genes. Previous studies have shown that sodium bicarbonate induces
CT expression in the V. cholerae El Tor biotype. However, the mechanism for
bicarbonate-mediated CT induction has not been defined. In this study, we
demonstrate that bicarbonate stimulates virulence gene expression by enhancing
ToxT activity. Both the classical and El Tor biotypes produce inactive ToxT
protein when they are cultured statically in the absence of bicarbonate. Addition
of bicarbonate to the culture medium does not affect ToxT production but causes
a significant increase in CT and TCP expression in both biotypes.
Ethoxyzolamide, a potent carbonic anhydrase inhibitor, inhibits bicarbonatemediated virulence induction, suggesting that conversion of CO2 into bicarbonate
by carbonic anhydrase plays a role in virulence induction. Thus, bicarbonate is
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the first positive effector for ToxT activity to be identified. Given that bicarbonate
is present at high concentration in the upper small intestine where V. cholerae
colonizes, bicarbonate is likely an important chemical stimulus that V. cholerae
senses and that induces virulence during the natural course of infection.
INTRODUCTION
Cholera is a human disease that is characterized by massive loss of water
and electrolytes, which leads to severe dehydration and hypovolemic shock if the
condition is not treated. The causative agent of cholera is Vibrio cholerae, a
highly motile, gram-negative, curved rod having a single polar flagellum. V.
cholerae strains are classified into serogroups based on the lipopolysaccharide O
antigen, and more than 200 serogroups have been identified to date. Only
serogroups O1 and O139 are responsible for epidemic and pandemic cholera
(145, 149). Serogroup O1 can be further divided into two biotypes, classical and
El Tor, based on biochemical properties and susceptibility to bacteriophages (44,
149). Classical biotype V. cholerae strains are thought to have caused the first
six cholera pandemics, beginning in 1817, whereas the El Tor biotype has been
responsible for the seventh pandemic, which has been ongoing since 1961 (44,
149).
A major difference between the classical and El Tor biotypes is that they
require different in vitro growth conditions for virulence gene induction. The
classical biotype is cultured in LB medium at 30°C and pH 6.5 for maximal
virulence gene expression and is cultured in LB medium at 37°C and pH 8.5 for
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minimal virulence gene expression (125). The El Tor biotype is cultured under
biphasic conditions termed AKI conditions for maximal virulence gene expression
(82-84). During the first phase, the bacteria are cultured for several hours
statically in a stationary tube in AKI medium, which contains 1.5% peptone, 0.3%
yeast extract, and 0.5% NaCl (82). During the second phase, an aliquot is
vigorously aerated and cultured for another several hours. Cholera toxin (CT)
expression in the El Tor biotype was also observed when bacteria were grown in
AKI media supplemented with 0.3% sodium bicarbonate under strictly static
conditions (83). The mechanisms that induce virulence gene expression under
either of these conditions are unknown.
Growth under virulence-inducing conditions results in production of the
two major virulence factors, CT and toxin-coregulated pilus (TCP) (125, 176,
177), as well as an assortment of other gene products having functions that are
poorly understood (43, 61, 62, 73, 74, 136). CT and TCP are absolutely required
for V. cholerae to cause cholera. CT, a classical AB toxin composed of
pentameric B subunits and one enzymatic A subunit (52, 110), is encoded by the
ctxAB genes in the genome of a filamentous bacteriophage (CTX) (186). The CT
A subunit ADP ribosylates a regulatory G protein in the intestinal epithelium,
leading to constitutive adenylate cyclase activity and subsequent hypersecretion
of water and electrolytes (149). This results in the voluminous watery diarrhea
that is the hallmark of cholera. TCP is a type IV pilus that is encoded in the tcpA
operon on the Vibrio pathogenicity island and aids in the formation of
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microcolonies during colonization of the intestinal epithelial lining (89, 177, 179).
TCP also acts as the receptor for CTX, which allows nontoxigenic V. cholerae
carrying the Vibrio pathogenicity island to acquire the CT genes (186).
The regulation of V. cholerae virulence gene expression is complex (117).
The V. cholerae virulence genes have collectively been known as the ToxR
regulon due to the central role that the ToxR protein plays in activating virulence
gene expression. However, the major direct transcription activator of the
virulence genes is the ToxT protein. ToxT is produced by the action of the
transcription activators ToxR and TcpP (39, 65, 67, 100). Once produced, ToxT
activates transcription of many virulence genes, including tcpA and ctxAB,
leading to pathogenesis (75, 190-192, 197, 198). ToxR has also been shown to
play a role in virulence gene expression independent of ToxT. Studies of
classical biotype V. cholerae have shown that ToxR alone can induce CT
production in the presence of bile (76). However, the amount of secreted toxin is
very small compared to the amount of secreted toxin produced in a ToxTdependent manner, and this ToxR-dependent expression has not been observed
in El Tor strains or in vivo (103).
ToxT belongs to the large AraC/XylS family of transcription regulators
(68). The carboxyl terminus of ToxT, corresponding to the conserved AraC family
domain, contains two helix-turn-helix motifs that are utilized for DNA binding
(114). The amino terminus does not share similarity with any protein in the
databases and is hypothesized to be involved in dimerization and/or interaction
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with an effector(s) that modulates ToxT activity (141). Bile and bile components
have been shown to decrease ToxT activity, perhaps through direct binding by
ToxT (28, 57, 152). However, no positive effector for ToxT activity has been
identified.
While the in vivo signals that induce V. cholerae virulence gene
expression have not been determined, V. cholerae has been shown to modulate
the expression of its virulence genes in vitro in response to environmental factors
and conditions, such as temperature, pH, osmolarity, chemotaxis toward certain
amino acids, and bile salts (28, 57, 125, 152). Another potential inducer of
virulence gene expression is sodium bicarbonate, which is included in some El
Tor AKI media (83) and is present at a high concentration in the upper small
intestine, which V. cholerae colonizes. Sodium bicarbonate protects the small
intestine from the acidity of fluid arriving from the stomach and is secreted by the
pancreatic duct epithelium at concentrations ranging from 70 to 140 mM (69).
Data from human volunteers indicated that the infectious dose of V. cholerae
decreased from 108 to 104 cells when volunteers were fed 2 g of sodium
bicarbonate along with the inoculum (24). Although the interpretation of these
data was that administration of bicarbonate enhanced survival of the bacteria in
the acidic environment of the stomach, an alternative explanation is that
bicarbonate could induce virulence gene expression, signaling to the bacteria
that they are entering a human host. The bicarbonate ion has been shown to
promote virulence gene expression in other bacteria, such as Bacillus anthracis
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(189), Streptococcus pyogenes (22), enterohemorrhagic Escherichia coli (2), and
the murine pathogen Citrobacter rodentium (196).
To determine whether bicarbonate alone could induce expression of the V.
cholerae virulence genes, we monitored the effects of bicarbonate on expression
of TCP and CT in both classical and El Tor biotype V. cholerae. The data
strongly suggest that bicarbonate enhances virulence gene expression in both
biotypes in a ToxT-dependent manner. ToxT protein was observed in bacteria
grown with and without sodium bicarbonate in the growth medium, but virulence
gene expression was observed only if bicarbonate was present. Addition of a
carbonic anhydrase (CA) inhibitor caused a significant reduction in virulence
gene expression. Thus, we propose that bicarbonate induces V. cholerae
virulence gene expression by enhancing ToxT activity and that this may be the
primary mechanism for virulence gene induction in vivo.
MATERIALS AND METHODS
Strains and growth conditions. V. cholerae classical biotype strain
O395 and El Tor biotype strain E7946 and isogenic ∆toxT (25) and ∆toxR (100)
mutants of these strains were maintained at −70°C in LB medium containing 20%
glycerol. All strains were grown overnight in LB medium at 37°C and then
subcultured in AKI medium (83) in the presence or absence of 0.3% bicarbonate.
Sodium bicarbonate was freshly prepared and used on the day of the
experiment. The classical strains were subcultured in the AKI medium from an
overnight culture using a 1:100 dilution, while the El Tor strains were diluted
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1:1,000.
Plasmid and strain construction. A chromosomal tcpA-lacZ fusion was
constructed as follows. The V. cholerae O395 tcpA promoter region was
amplified by PCR with 500-bp segments on either side corresponding to the DNA
sequence surrounding the V. cholerae lac promoter. The product was cloned into
suicide vector pKAS32, transformed into E. coli SM10(λpir), and moved into V.
cholerae strain O395 by conjugation as previously described (162). Thus, PtcpA
replaced Plac as the promoter driving lacZ expression from the normal
chromosomal locus. A toxT::lacZ fusion plasmid was constructed by PCR
amplifying the toxT promoter from V. cholerae O395 genomic DNA and cloning it
into pTL61T (108) using XbaI and HindIII restriction sites. The tcpA::lacZ fusion
plasmid was constructed previously (191). An arabinose-inducible toxT plasmid
(pBAD-toxT) was constructed by amplifying the toxT gene from V. cholerae O395
genomic DNA and cloning it into pBAD33 (58) using XbaI and PstI restriction
sites.
RNA isolation and reverse transcription (RT)-PCR. Cell pellets
harvested at different time points during static growth or AKI growth were
collected by centrifugation. RNA was isolated using Trizol reagent (Invitrogen)
according to the manufacturer's protocol. Total RNA was subjected to DNase I
digestion for 1 h at 37°C to eliminate any DNA contamination. RNA was
recovered by ethanol precipitation and resuspended in RNase-free water. The
RNA concentration was adjusted to 5 µg/µl based on A260 measurement. To
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monitor the presence of toxT mRNA, an aliquot of each RNA sample was reverse
transcribed using SuperScript III reverse transcriptase (Invitrogen). This was
followed by PCR using Taq DNA polymerase (Denville Scientific) and an
Eppendorf Mastercycler gradient thermal cycler. The PCR conditions were as
follows: 60 s at 94°C, followed by 30 cycles of 30 s at 94°C for denaturation, 30 s
at 55°C for annealing, and 60 s at 72°C for extension and then 5 min at 72°C.
The upstream forward primer ATGATTGGGAAAAAATCTTTTC was used (the
underlined sequence is the start codon). The reverse primer sequence was
TCAAGATCATCAGTAATAAATATAG (the underlined codon is complementary to
the leucine codon at position 168 of ToxT relative to the start codon).
β-Galactosidase and CT assays. β-Galactosidase activity was measured
using the basic procedure of Miller (122). CT was detected in the culture
supernatant by a GM1 enzyme-linked immunosorbent assay (ELISA) (173),
using polyclonal anti-CT antibody (Sigma). A positive control assay for
quantification of the level of CT in the samples was performed using purified CT
(List Biological Laboratories).
Immunodetection of ToxT. Aliquots of cells harvested at different time
points during growth were normalized based on the optical density at 600 nm and
resuspended in 10 µl water and 10 µl of 2X protein buffer (123 mM Tris-HCl, 4%
sodium dodecyl sulfate, 1.4 M 2-mercaptoethanol, 20% glycerol, 0.2%
bromophenol blue). The samples were boiled for 5 min and subjected to 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The gel was blotted
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on nitrocellulose paper for 2 h using a semidry electroblotter apparatus (Fisher
Scientific). Blots were incubated for 2 h in TBS buffer (20 mM Tris-HCl, 0.5 M
NaCl, 0.025% Tween 20; pH 7.5) containing 5% milk to reduce nonspecific
binding. After the blots were washed with TBS buffer, they were incubated
overnight in TBS buffer containing 5% milk and a 1:3,000 dilution of rabbit
polyclonal anti-ToxT serum. After three washes for a total of 15 min with TBS
buffer, each blot was incubated for 2 h in TBS buffer containing 5% milk and a
1:5,000 dilution of goat anti-rabbit immunoglobulin G conjugated to alkaline
phosphatase (Southern Biotech). After the blots were washed with TBS buffer,
they were developed using 5 ml of immuno-BCIP (5-bromo-4-chloro-3indolylphosphate)—nitroblue tetrazolium liquid substrate (Invitrogen).
RESULTS
Sodium bicarbonate stimulates CT and TCP production. To begin our
investigation into the effects of bicarbonate on V. cholerae virulence gene
expression, we assessed expression of the tcpA and ctxAB operons. Previous
work indicated that CT was produced by El Tor V. cholerae cells when the
bacteria were grown in a stationary tube (static conditions) in the presence of
bicarbonate (83). CT was not detected when the cells were cultured under the
same conditions in the absence of bicarbonate. However, adding a shaking
phase after the static growth phase resulted in production of high levels of CT
regardless of the presence of bicarbonate in the medium (82). We repeated
these experiments using a CT ELISA to measure CT production and β-
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galactosidase assays to measure tcpA::lacZ expression. CT and β-galactosidase
levels were measured at 3, 4, 5, and 6 h after subculturing and again after 4 h of
shaking for AKI conditions.
Our results indicate that bicarbonate does indeed induce expression of
both CT and TCP under static growth conditions. As shown in Fig. 5A, CT was
expressed at very low or undetectable levels when V. cholerae El Tor strain
E7946 was grown statically in the absence of bicarbonate. High levels of CT
were expressed when the E7946 strain was grown statically in the presence of
0.3% sodium bicarbonate. CT expression peaked at 4 h after subculturing and
remained stable during the rest of the experiment (Fig. 5A). An isogenic V.
cholerae strain in which toxT, which encodes the major activator of ctxAB and
tcpA transcription, was deleted did not produce detectable levels of CT at any
time point under any growth conditions, indicating that the observed CT
production required ToxT protein activity.
Induction of tcpA transcription was also observed to be dependent on both
bicarbonate and ToxT. β-Galactosidase production from a plasmid-borne
tcpA::lacZ fusion in E7946 was measured at 3, 4, 5, and 6 h after subculturing in
medium either containing or lacking 0.3% sodium bicarbonate (Fig. 5B). In
contrast to the very low CT production that we observed when bacteria were
grown under static conditions in media lacking bicarbonate, some tcpA::lacZ
expression was observed over the time course in the absence of bicarbonate,
starting at 4 h after subculturing. However, the β-galactosidase levels were much
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higher when the bacteria were grown in the presence of 0.3% sodium
bicarbonate. Once again, an otherwise isogenic ∆toxT strain did not produce
significant β-galactosidase activity at any time point or under any growth
conditions. These results demonstrate that bicarbonate stimulates the expression
of tcpA and ctxAB and that this stimulation is toxT dependent.
Under AKI growth conditions, which include an additional shaking phase
after the static growth phase, CT production was observed to be much higher if
bicarbonate was present in the growth medium, but tcpA::lacZ expression was
similar in the presence and in the absence of bicarbonate (Fig. 5A and B). Similar
results were obtained using El Tor strains C6706 and N16961 (data not shown).
An otherwise isogenic ∆toxT strain did not produce significant CT or βgalactosidase activity under AKI conditions, confirming that the induction of
virulence gene expression under AKI conditions is ToxT mediated.
To determine whether bicarbonate also induces virulence gene expression
in classical biotype V. cholerae, CT production and tcpA-lacZ expression in
classical strain O395 were measured. Previously, it was found that some
classical strains produced CT under AKI conditions, whereas other did not (82).
Our results indicate that bicarbonate induces virulence gene expression in
classical V. cholerae strain O395. Both CT levels (Fig. 5C) and β-galactosidase
production from a chromosomal tcpA-lacZ fusion (Fig. 5D) were greatly
increased by addition of 0.3% bicarbonate to the growth medium. AKI growth
conditions with medium lacking bicarbonate resulted in some induction of CT and
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tcpA-lacZ expression, but addition of bicarbonate under AKI conditions still
caused a significant increase in CT and tcpA-lacZ expression. No significant CT
or tcpA-lacZ expression was observed in an isogenic O395 ∆toxT strain under
any conditions (data not shown).
The pH of AKI medium increased from 7.0 to 7.2 when 0.3% bicarbonate
was added. To rule out the possibility that the induction of virulence was due to
the pH difference, we measured the expression of tcpA::lacZ after the starting pH
of AKI medium was increased to 7.2 with sodium hydroxide. No significant
induction was observed for either El Tor strain E7946 or classical strain O395
(Fig. 6). The pH of the culture with added bicarbonate remained 7.2 during 4 h of
static growth, whereas the pH of the culture whose pH was raised to 7.2 with
NaOH dropped to 6.8 during 4 h of static growth, indicating that bicarbonate
buffers the medium. Addition of morpholinepropanesulfonic acid (MOPS) buffer
to AKI medium with a starting pH of 7.2 kept the pH at 7.2 during 4 h of static
growth but had no effect on virulence gene expression unless bicarbonate was
also added (data not shown). Overall, these results demonstrate that bicarbonate
induces tcpA and ctxAB expression in El Tor and classical V. cholerae strains
and that this induction is ToxT dependent.
toxT mRNA production is

independent of bicarbonate. toxT

transcription is initially activated by the inner membrane protein pairs ToxR-ToxS
and TcpP-TcpH (39, 65, 67, 100). Once ToxT protein is expressed, it can
produce more of itself by activating transcription of the tcpA operon, in which the
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toxT gene is located (197). One possible explanation for the minimal virulence
gene expression observed when V. cholerae was cultured under static conditions
in the absence of bicarbonate is that the initial activation of toxT did not occur. To
examine this possibility, we analyzed the effects of bicarbonate on βgalactosidase production from a toxT::lacZ reporter plasmid. Because the
reporter is plasmid based and not located downstream of tcpA, ToxT should have
no effect on its expression. When V. cholerae was grown in the absence of
bicarbonate, the amount of β-galactosidase activity per cell was larger than the
amount when V. cholerae was grown in the presence of bicarbonate (Fig. 7A),
strongly suggesting that bicarbonate is not required for and does not positively
affect toxT transcription. Addition of bicarbonate to the growth medium caused a
~50% reduction in toxT::lacZ expression at every time point. Regardless of the
presence of bicarbonate, toxT::lacZ expression peaked at 4 h after subculturing,
consistent with the ToxT-dependent CT and tcpA::lacZ expression peaks shown
in Fig. 5. As a control, β-galactosidase production by a ∆toxR strain that harbors
the same toxT::lacZ fusion plasmid was also measured. The toxT::lacZ
expression in the ∆toxR strain was low at all time points, and no effect of
bicarbonate was observed, confirming that toxT transcription is ToxR dependent
and bicarbonate independent.
To directly assess whether the toxT mRNA level or stability was affected
by bicarbonate, RT-PCR experiments using primers specific for the toxT gene
were performed (Fig. 7B). toxT transcripts were present under both static and
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AKI growth conditions regardless of the presence of bicarbonate. These results
indicate that the effect of bicarbonate on virulence gene expression is mediated
downstream from toxT transcription.
ToxT protein is produced but inactive in the absence of bicarbonate.
Because toxT mRNA production was not dependent on bicarbonate, we next
investigated whether ToxT protein production was dependent on bicarbonate.
Bicarbonate could possibly act at the translational level, affecting ToxT protein
synthesis, or at the protein level, affecting ToxT activity. Using polyclonal
antibodies specific for ToxT, we assessed by Western blotting whether ToxT
protein was produced in V. cholerae grown in the presence or absence of
bicarbonate. Our results paralleled the results that we obtained for toxT mRNA
expression. ToxT protein was stably produced regardless of the presence of
bicarbonate in the growth medium (Fig. 8). Using cell extracts harvested from El
Tor strain E7946 after 4 h of static growth in medium either containing or lacking
bicarbonate, a ToxT-specific band was visible in Western blots under both growth
conditions (Fig. 8A, lanes 3 and 4). An isogenic ∆toxT strain did not produce this
band (Fig. 8A, lane 2).
Similar results were obtained using cell extracts from classical strain
O395. At the 4- and 6-h time points, a ToxT-specific band that corresponded to
purified ToxT protein was observed (Fig. 8B, lanes 1, 3, 4, 6, and 7). An isogenic
∆toxT strain did not produce this band (Fig. 8B, lane 2). The ToxT-specific band
was also observed for extracts of O395 grown under AKI conditions (Fig. 8B,
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lanes 5 and 8). However, the ToxT levels in bacteria grown under AKI conditions
with bicarbonate were significantly lower; the reasons for this are unclear.
Paralleling the toxT::lacZ expression results indicating that toxT transcription was
lower in the presence of bicarbonate, lower ToxT protein levels were observed in
cells grown in the presence of bicarbonate in general, strongly suggesting that
bicarbonate does not increase ToxT protein expression or stability.
Over-expression of ToxT can compensate for the absence of
bicarbonate. The experimental results described above are consistent with a
model in which bicarbonate positively affects ToxT activity rather than ToxT
expression levels. Previous work indicated that ToxT expression from a plasmid
in V. cholerae or E. coli resulted in activation of virulence factor transcription,
even under virulence-repressing growth conditions (198). To investigate whether
this over-expression of ToxT could compensate for the absence of bicarbonate
as the inducing agent, we constructed a plasmid carrying toxT fused to ParaBAD
(pBAD-toxT). ToxT expression can be induced from pBAD-toxT by addition of
0.2% arabinose to the growth medium. This plasmid was transformed into our
E7946 ∆toxT derivative, and CT production and ToxT protein levels in the new
strain were then measured.
Our results indicate that ToxT was indeed overproduced from the pBADtoxT plasmid and that this resulted in increased CT production. In Western blot
experiments (Fig. 8A, lanes 5 and 6) much higher levels of ToxT were present in
extracts of the E7946 ∆toxT strain carrying pBAD-toxT than in extracts of wild-
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type strain E7946 carrying the pBAD33 vector. CT production was approximately
sixfold greater in the E7946 ∆toxT strain carrying pBAD-toxT than in wild-type
strain E7946 carrying the pBAD33 vector when both strains were grown in the
absence of bicarbonate (Fig. 9). The CT production by the E7946 ∆toxT strain
carrying pBAD-toxT grown without bicarbonate was remarkably similar to the CT
production by wild-type strain E7946 carrying the pBAD33 vector grown with
bicarbonate. However, bicarbonate still increased CT expression in the E7946
∆toxT strain carrying pBAD-toxT more than twofold, suggesting that ToxT activity
could be enhanced by bicarbonate even when ToxT levels are far higher than
normal.
A CA inhibitor, ethoxyzolamide (EZA), inhibits the effect of
bicarbonate on virulence induction. The results described above strongly
suggest that bicarbonate induces ToxT-dependent V. cholerae virulence gene
expression. In mammals, bicarbonate is secreted by the pancreas into the upper
small intestine at a concentration of ~140 mM (69). V. cholerae colonizes the
upper small intestine and therefore encounters high levels of bicarbonate during
the course of infection. Bicarbonate could enter bacterial cells by at least two
routes. First, bicarbonate and CO2 are interconvertible in aqueous solution. CO2
can enter the bacterial cell by passive diffusion and then be converted into
bicarbonate by CA. Second, bicarbonate transporters can directly bind to
bicarbonate and import it into the cell. Recent studies of other pathogens that
utilize bicarbonate/CO2 to induce virulence have produced different results
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regarding the effects of CA inhibition. Inhibition of CA reduces virulence
activation in C. rodentium (196) but has no effect on B. anthracis (189). These
results suggest that C. rodentium utilizes CA to accumulate bicarbonate in the
cell, while B. anthracis mainly utilizes direct bicarbonate transport.
To determine whether CA inhibition affects bicarbonate-mediated virulence
induction in V. cholerae, we measured β-galactosidase production from
tcpA::lacZ in the presence of EZA in both classical (O395) and El Tor (E7946) V.
cholerae strains. Addition of 400 µM EZA resulted in a >50% reduction in
tcpA::lacZ expression in both E7946 and O395 grown with bicarbonate in the
medium (Fig. 10). The effect of EZA was observed in bacteria grown under both
static and AKI conditions. In the absence of bicarbonate, EZA had no effect when
V. cholerae was cultured under static conditions but caused 50% inhibition of
tcpA::lacZ expression when V. cholerae was cultured under AKI conditions,
suggesting that the shaking phase of AKI conditions mimics the presence of
bicarbonate in static culture. EZA had no detectable effect on V. cholerae growth
rates. These data suggest that CA plays an important role in V. cholerae
virulence induction by modulating intracellular bicarbonate levels.
DISCUSSION
Sodium bicarbonate has previously been found to induce CT production in
the El Tor biotype of V. cholerae (82, 83), but the mechanism for this induction
was unknown. Medrano et al. (118) found that ToxR-dependent toxT transcripts
were produced when El Tor biotype V. cholerae was cultured under static
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conditions in the absence of bicarbonate. However, ToxT activity in terms of
increased ctxAB transcription was not detected. These results suggested that the
ToxT protein was either present but inactive or not present when the cells were
cultured statically in the absence of bicarbonate. Here we have shown that the
initial activation of the toxT promoter by ToxR-ToxS and TcpP-TcpH occurs when
the bacteria are cultured statically in the presence or absence of bicarbonate.
These results are in agreement with previous data showing that transient
expression of toxT occurs during the static phase under AKI conditions (118).
Moreover, our data indicate that the ToxT protein was present but had minimal
activity in both the classical and El Tor biotypes when bacteria were grown in the
absence of bicarbonate. Growing the bacteria with bicarbonate in the medium
enhances the activity of ToxT, and both CT production and tcpA promoter
activation are maximally induced. This bicarbonate-mediated virulence induction
is ToxT dependent, as the isogenic toxT deletion strains did not express
virulence genes in the presence of bicarbonate.
The V. cholerae in vitro virulence-inducing conditions do not resemble the
conditions that V. cholerae encounters in the small intestine. The classical
biotype is cultured in LB medium at pH 6.5 and 30°C for maximum virulence
gene induction (125). Neither low temperature nor low pH occurs in the upper
small intestine that V. cholerae colonizes. The El Tor biotype is cultured in rich
medium statically for several hours, followed by shaking for several more hours,
for maximal virulence gene induction (82). Again, these conditions are not found
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in the upper small intestine. The presence of bicarbonate is not required for CT
production and tcpA::lacZ expression under AKI conditions, although bicarbonate
does increase the amount of CT produced. However, static growth conditions
with bicarbonate in the medium might more closely mimic what happens during
the course of infection, as V. cholerae is grown at 37°C, with exposure to very
low levels of oxygen, and in the presence of bicarbonate, all of which are similar
to conditions in the small intestine. Based on the evidence that we obtained
regarding the requirement of bicarbonate for maximal ToxT activity and knowing
that bicarbonate is present at high concentrations in the small intestine, we
propose that V. cholerae utilizes bicarbonate during infection as an effector
molecule to induce virulence.
Bicarbonate could also be responsible for the temporal regulation of
virulence that has been observed in vivo. Bicarbonate is produced by pancreatic
cells and secreted into the lumen of the small intestine to neutralize the acid that
comes from the stomach. Lee et al. (103) have observed that during infection
tcpA expression is induced in two stages, while ctxAB expression is induced
subsequent to the second stage of tcpA induction. On the basis of these results,
these authors proposed a model for temporal regulation in which the primary
pulse of tcpA expression allows the bacteria to colonize the epithelial lining and
in response to a second signal ctxAB expression is induced. Studies have shown
that there is a pH gradient in the mucus gel in the human duodenum (144),
suggesting that the concentration of bicarbonate is higher close to the epithelial
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surface, so bicarbonate could be the second signal that stimulates maximum
virulence induction.
The following model describes a mechanism for bicarbonate-mediated
virulence gene induction and its involvement in temporal regulation patterns (Fig.
11). As the bacteria enter the lumen of the small intestine, they encounter the
primary signal, which remains unclear and which induces transcription of toxT. In
the lumen, lower levels of pancreatic bicarbonate are present due to diffusion
throughout the intestine. The low concentration of bicarbonate produces low
levels of ToxT activity, resulting in a low level of tcpA expression. At later stages
of infection, the bacteria enter the mucus layer, where they encounter a higher
concentration of bicarbonate that is secreted by the epithelial cells. This leads to
enhanced ToxT activity and maximal tcpA and CT expression.
Bicarbonate has the same effects on ToxT protein activity and virulence
gene expression in both the classical and El Tor V. cholerae biotypes. This
suggests that the mechanism of bicarbonate-mediated enhancement of ToxT
activity is conserved. Bicarbonate could act as a positive effector molecule and
directly modulate ToxT protein activity, or it could act indirectly to enhance ToxT
function. Recent work on RegA of C. rodentium, which like ToxT shares
sequence homology with the AraC/XylS protein family, has shown that
bicarbonate stabilizes RegA binding to promoter regions. Addition of bicarbonate
in vitro resulted in different migration patterns of RegA-DNA complexes in
electrophoretic mobility shift assay (EMSA) experiments (196). ToxT binds to
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promoter DNA sequences in vitro without bicarbonate (190-192, 198). We tested
for a similar direct effect of bicarbonate on ToxT-DNA complexes using EMSA.
However, no differences in the binding profiles were observed after addition of
bicarbonate to the binding reaction mixtures (data not shown). Although we did
not observe direct effects of bicarbonate on ToxT using the EMSA technique, the
possibility that bicarbonate directly binds to the ToxT protein and modulates its
activity cannot be ruled out. The possible mechanisms for modulation of ToxT
activity by bicarbonate include enhancing the binding affinity of ToxT for
toxboxes, enhancing the interaction between DNA-bound ToxT monomers,
enhancing the interactions between ToxT and RNA polymerase, and some other
direct mechanisms. Our data indicating that overexpression of ToxT can
compensate for the absence of bicarbonate in the growth medium suggest that
bicarbonate may enhance the binding affinity of ToxT for its DNA or protein
partners. Thus, an increased ToxT concentration compensates for reduced ToxT
binding affinity.
Indirect effects of bicarbonate on ToxT are also possible. Bicarbonate
could induce or modulate gene products to enhance the activity of ToxT. Sträter
et al. have found that bicarbonate ion activates E. coli aminopeptidase A (PepA)
(172). The pepA gene product is a multifunctional protein. It has peptide
proteolysis activity (27), acts as a repressor involved in regulation of the
carboamoylphosphate synthetase operon (35), and plays a role in site-specific
recombination at the ColE1 site, a mechanism that is involved in resolving
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multimers of multicopy plasmids into monomers to allow stable heredity of the
plasmids (168). The X-ray crystallographic structure of PepA indicated that a
bicarbonate anion is bound to an arginine side chain (171). Interestingly, deletion
of the V. cholerae pepA gene has also been shown to increase the levels of CT,
tcpA, toxT, and tcpP when the cells are cultured under ToxR-repressing
conditions (LB medium at pH 8.5 and 37°C) (10). One possible indirect effect of
bicarbonate is that pepA or other gene products negatively regulate the activity of
ToxT and addition of bicarbonate could modify such gene products to relieve this
inhibition.
Bacteria can increase cytosolic bicarbonate levels through at least two
routes. First, transporters can directly bind to and import bicarbonate. The
cmpABCD gene cluster encodes the bicarbonate transport system of
Synechococcus elongatus PCC 6301 (112). Proteins with sequence homology to
proteins in this system have been shown to play a role in B. anthracis
pathogenesis (189). However, BLAST searches of the V. cholerae genome have
yielded no sequences having homology to this system. This suggests either that
V. cholerae does not utilize transporters to accumulate cellular bicarbonate or
that V. cholerae utilizes a different system of transporters to import bicarbonate.
Second, both metabolic CO2 and atmospheric CO2 that enter the cell by simple
diffusion are converted into bicarbonate by the action of CA. CAs are zinc
metalloenzymes that catalyze the hydration of CO2 into bicarbonate. CAs have
been shown to be involved in many cellular processes, such as photosynthesis,
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respiration, CO2 transport, and cyanate metabolism in E. coli (164). CAs are
classified into three classes, α, β, and γ, and they share little sequence homology
with each other but catalyze the same reaction. V. cholerae encodes one
putative CA homolog belonging to each class; the cah gene (VC0395_0957)
product belongs to the α class; the putative gene VC0395_A 0118 product
belongs to the β class; and the putative VC0395_A2463 product belongs to the γ
class. Our data indicate that addition of the CA inhibitor EZA resulted in a >50%
reduction in tcpA promoter activity. This suggests that one or more of the putative
CAs and/or other CA-like molecules play a role in virulence induction in V.
cholerae. Notably, EZA also caused a decrease in virulence gene expression
under AKI conditions in the absence of bicarbonate. This finding suggests that
the shaking phase of AKI conditions has an effect that is similar to addition of
bicarbonate to a static culture and that the induction of virulence gene expression
induced by both bicarbonate and AKI conditions is due to increased cytosolic
bicarbonate levels mediated by one or more of the V. cholerae CAs.
Culturing V. cholerae under AKI conditions likely mimics the presence of
bicarbonate in the medium by increasing the CO2 concentration in the medium.
CO2 and HCO3− freely interconvert in solution, so an increase in the CO2
concentration would result in an increase in the bicarbonate concentration.
Production of CT has been observed when the El Tor biotype was cultured in the
absence of bicarbonate. However, either a shaking period or culturing the
bacteria with a low ratio of volume to surface area was required (82, 150). Under
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these conditions, V. cholerae could produce enough CO2 so that there was an
increase in cellular bicarbonate levels. The increase in bicarbonate levels could
occur through direct transport of bicarbonate by the bacteria and/or through CO2
uptake and conversion into bicarbonate by CAs. Increasing the cellular
bicarbonate level would enhance ToxT activity so that CT was maximally
expressed. In the absence of bicarbonate, V. cholerae produces mainly CO2 as a
product of metabolism. When the bacteria are grown under static conditions with
a small exposed surface area, the amount of CO2 produced by the cells is
relatively small as the growth rate is low. CO2 diffuses out of the cells at a rate
greater than the rate of conversion into cellular bicarbonate by CA. The low level
of bicarbonate produced by CA under these conditions is not sufficient to induce
virulence. In contrast, addition of a shaking period or culturing using a large
exposed surface area increases the growth rate due to aerobic metabolism, and
thus the cells produce more CO2. The higher level of CO2 could increase the
cytoplasmic level of bicarbonate, and virulence gene expression would be
induced. It has been reported that under anaerobic growth conditions in either
classical virulence-inducing medium (classical biotype) (99, 113) or syncase
medium (El Tor biotype) (113) TCP expression is observed but CT production is
low or nonexistent. This is somewhat similar to the expression patterns that we
observed under AKI conditions in the absence of bicarbonate, in which a high
level of tcpA expression but a low level of CT production was observed (Fig. 5).
Both of these growth conditions may mimic the early stages of infection shown in
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Fig. 11, in which the bicarbonate concentration is relatively low. A possible
mechanism for the observed differential expression of CT and TCP under lowbicarbonate conditions arises from the observation that H-NS is a major negative
regulator of ctx transcription (51, 134), whereas H-NS has little or no effect on
tcpA transcription (198). When bicarbonate levels are low, a small pool of
“activated” ToxT may be blocked from binding to the ctx promoter by H-NS but
may bind to the tcpA promoter unhindered and activate its transcription.
In summary, we have found that bicarbonate induces expression of the V.
cholerae major virulence factors by enhancing the activity of the ToxT protein
that is already present in the bacteria. This is the first example of a positive
effector for ToxT activity, and bicarbonate is likely to be an important in vivo
signal that induces V. cholerae virulence gene expression during infection.
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FIG. 5. Effect of bicarbonate on CT and tcpA::lacZ expression. Open bars, wildtype V. cholerae grown without bicarbonate; dark gray bars, wild-type V. cholerae
grown with 0.3% bicarbonate; light gray bars, V. cholerae ∆toxT mutant grown
with 0.3% bicarbonate. (A) CT production by El Tor strain E7946. (B) βGalactosidase produced from plasmid-borne tcpA::lacZ in El Tor strain E7946.
(C) CT production by classical strain O395. (D) β-Galactosidase produced from
chromosomal tcpA-lacZ in classical strain O395. Statistical significance was
determined by Student's t test (*, P < 0.025; **, P < 0.005; ***, P < 0.0005).
OD600, optical density at 600 nm; WT, wild type.

57

FIG. 6. Effect of pH on tcpA expression. V. cholerae were grown for 4 hours in a
static tube in AKI medium. Light gray bars indicate neither NaOH nor bicarbonate
were added to the medium, white bars indicate NaOH was added to adjust
starting pH to 7.2, and dark gray bars indicate 0.3% bicarbonate was added,
which changed pH to 7.2. A. β-galactosidase produced from plasmid-borne
tcpA::lacZ in El Tor strain E7946. B. β-galactosidase produced from
chromosomal tcpA-lacZ in classical strain O395. Statistical significance was
determined by Student’s T test with * indicating P <0.0025 and ** indicating P <
0.0001.
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FIG. 7. Bicarbonate does not increase toxT transcription. (A) β-Galactosidase
produced from plasmid-borne toxT::lacZ in El Tor strain E7946. Light gray bars,
V. cholerae ∆toxR mutant grown without bicarbonate; black bars, V. cholerae
∆toxR mutant grown with 0.3% bicarbonate; open bars, wild-type V. cholerae
grown without bicarbonate; dark gray bars, wild-type V. cholerae grown with
0.3% bicarbonate. Statistical significance was determined by Student's t test (*, P
< 0.02). WT, wild type. (B) RT-PCR to detect toxT mRNA in whole-cell RNA
preparations. − RT, no RT was performed before PCR; + RT, RT was performed
before PCR. Lane M contained molecular weight standards, and 4 hr and 6 hr
indicate the time of growth in a stationary tube. AKI indicates addition of a
shaking phase of growth. The presence or absence of bicarbonate in the growth
medium is indicated below the gels.
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FIG. 8. Detection of ToxT protein in V. cholerae grown in the presence or
absence of bicarbonate. ToxT protein was detected by Western blotting using
polyclonal anti-ToxT antibodies. 6His-ToxT, purified His-tagged ToxT protein
loaded as a control. (A) El Tor strain E7946. The presence or absence of
bicarbonate in the growth medium is indicated above the lanes. E7946 ∆toxT +
pBAD-toxT indicates that the ∆toxT strain was complemented in trans with
pBAD-toxT and arabinose was included in the growth medium. (B) Classical
strain O395. 4 hr and 6 hr indicate the time of growth in a stationary tube, and
AKI indicates that a shaking phase of growth was added. Lane M contained
protein molecular weight markers.
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FIG. 9. Effect of ToxT overproduction from pBAD-toxT on CT production in V.
cholerae El Tor strain E7946. Open bars, bacteria grown without bicarbonate;
gray bars, bacteria grown with 0.3% bicarbonate. Both strains were grown
statically for 6 h in the presence of arabinose before a CT ELISA was performed.
E7946 ∆toxT + pBAD-toxT indicates that the ∆toxT E7946 strain was
complemented in trans with pBAD-toxT, and E7946 + pBAD33 indicates wildtype V. cholerae carrying the empty pBAD33 vector. Statistical significance was
determined by Student's t test (*, P < 0.005). OD600, optical density at 600 nm.
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FIG. 10. Effects of the CA inhibitor EZA on tcpA::lacZ expression. Gray bars,
dimethyl sulfoxide (DMSO) alone added to the growth medium; open bars, EZA
dissolved in dimethyl sulfoxide added to the growth medium. (A) β-Galactosidase
produced from plasmid-borne tcpA::lacZ in El Tor strain E7946. (B) βGalactosidase produced from chromosomal tcpA-lacZ in classical strain O395.
Statistical significance was determined by Student's t test (*, P < 0.015; **, P <
0.005).

62

FIG. 11. Model for induction of virulence gene expression by bicarbonate in vivo.
On the left, motile V. cholerae containing inactive ToxT protein enters the upper
small intestine. In the center, V. cholerae in the intestinal lumen encounters
bicarbonate, ToxT becomes active, and TCP production begins. On the right,
bacteria entering the mucus layer encounter higher levels of bicarbonate,
virulence genes are fully induced, and CT production begins. The gradient of
increasing bicarbonate levels from the lumen to the mucosal surface is indicated
by the triangle on the right.
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CHAPTER TWO
Regulation of Vibrio Cholerae Virulence by Proteolysis of ToxT
ABSTRACT
Vibrio cholerae is a gram negative bacterium that is the causative agent of
the severe diarrheal illness, cholera. While over 200 different V. cholerae
serogroups have been identified, only serogroups O1 and O139 have exhibited
the ability to cause epidemics. V. cholerae O1 is further divided into two biotypes,
classical and El Tor. For the classical biotype, maximal virulence induction in vitro
requires growing the bacteria at 30º C in LB at starting pH 6.5 (ToxR-inducing
conditions). In contrast, minimal virulence induction results when the cells are
cultured at 37º C in LB at starting pH 8.5 (ToxR-repressing conditions). Under
virulence inducing conditions, both the ToxR/S and TcpP/H heterodimers initially
activate toxT transcription. Once ToxT is expressed, it activates expression of the
two major virulence factors: cholera toxin (ctx operon) and toxin co-regulated
pilus (tcp operon). ToxT also produces more of itself via a positive feedback loop
by activating transcription of the tcp operon, within which toxT is located. It is
known that V. cholerae terminates virulence gene expression prior to escape
from the host, but it is unknown how the ToxT positive feedback loop is broken,
which is an essential step in terminating virulence gene expression. To
understand better the regulation of ToxT protein, we monitored its accumulation
and its activity under virulence inducing and repressing growth conditions. Our
results suggest that ToxT protein undergoes proteolytic degradation under

64

virulence repressing conditions. The degradation of ToxT under repressing
conditions suggests a model for terminating V. cholerae virulence gene
expression during the late stage of infection, with both ToxT and TcpP undergoing
proteolysis prior to escaping the host.
INTRODUCTION
Vibrio cholerae, the causative agent of severe dehydrating diarrhea, uses
a complex array of gene regulation to control virulence gene expression during
infection (117). ToxT is the direct transcriptional activator that induces expression
of most virulence factors including the cholera toxin (CT) and the toxin coregulated pilus (TCP) (75, 190-192, 197, 198). CT is responsible for fluid loss into
the intestinal milieu that results from the constitutive production of cAMP by the
intestinal epithelial cells (45, 53). CT is an AB5 toxin composed of five B subunits
that binds to the GM1 ganglioside receptor of the epithelial cells, and an
enzymatic A subunit that upon activation modifies adenylyl cyclase by adding an
ADP-ribosyl group and keeps it in its active state (52, 110). The TCP is a type IV
pilus that is thought to be involved in bacteria-bacteria interaction to form
microcolonies and enhance colonization over the epithelial cells that line the
small intestine (89, 177, 179).
ToxT protein belongs to the AraC/XylS family of proteins (68) that directly
binds to virulence gene promoters of V. cholerae, recruits RNA polymerase and
positively activates these promoters (75, 191, 198). It is composed of 276 amino
acids that are separated into two domains: The N-terminal domain (NTD)
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comprises amino acids 1-160, whereas the C-terminal domain comprises amino
acids 170-276. These two domains are connected by a short linker, amino acids
161-169 (111). The ToxT CTD is a conserved AraC/XylS family domain, having
two helix-turn-helix motifs that are utilized for DNA binding. The NTD does not
share significant sequence similarity with any protein in the database and its role
is hypothesized to be dimerization and/or interacting with effectors that modulate
ToxT activity. However, the crystal structures of ToxT protein and the AraC
protein NTD indicate that the ToxT NTD and the AraC NTD share some
structural similarity despite having only 11% amino acid identity (111). The AraC
NTD is required for dimerization and binding to its effector, arabinose (114). It
has been proposed that bile or the unsaturated fatty acids (UFA) present in bile
are natural effectors of ToxT. Bile and UFA have been shown to inhibit ToxT
activity and the overall growth of V. cholerae (28, 57, 141-143, 152, 188).
Mutational analysis demonstrated that bile might interact with the N-terminal
domain of ToxT, as a ToxT mutant somewhat resistant to bile was isolated that
had a single amino acid change at residue 107 (141). Furthermore, the crystal
structure of ToxT contains a buried 16-carbon UFA, cis-palmitoleate, which
inhibits the activity of ToxT and may be a minor component of crude bile (111). A
synthetic inhibitor of ToxT activity, virstatin, also apparently interacts with the
ToxT NTD (155).
toxT expression is controlled by two promoters. Initially, activation of toxT
transcription occurs via the activity of the two membrane localized heterodimers,
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toxR/S and tcpP/H (39, 65, 67, 100). ToxR and TcpP have been shown to bind to
the toxT proximal promoter to produce toxT transcripts. Deletion of toxR or tcpP
inhibits activation of this promoter and abrogates toxT mRNA production. Once
ToxT protein is present in the cells, a second, longer mRNA containing toxT is
produced from the distal tcpA promoter. Deletion of the tcpA promoter or the
ToxT helix-turn-helix motifs required to inactivate tcpA transcription decreases
toxT mRNA level (197). Furthermore, transposon insertions in the region
between tcpA and tcpF cause a polar effect on ToxT activity as determined by
measuring CT production and expression of a tcpA-lacZ fusion (16). These
results support a positive auto-regulatory mechanism that controls toxT
expression and activity.
While virulence induction has been vigorously studied in the past decade
and is characterized to some extent, repression of virulence once it has been
established is not well understood. Down-regulation of virulence genes including
those encoding TCP and CT during the late period of infection (in rice water
stool) has been observed (101, 121, 132) and has been proposed to be
important for environmental survival. In order for V. cholerae to shut down the
virulence cascade, two things must occur: 1) activation of the toxT promoter must
be curtailed, and 2) activation of the tcpA promoter auto-regulatory loop that
produces ToxT must be curtailed. In the former case, studies have shown that
the TcpP level is tightly controlled by expression and degradation processes,
which could provide a check point to turn on and off the toxT promoter (8, 23, 93,
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94, 116). tcpP expression requires two transcription activators, AphA and AphB,
and tcpP transcription is inhibited by cAMP-CRP, which is responsive to the
presence or absence of glucose as an available carbon source (96). Once TcpP
protein has been produced, it is degraded by a sequential event involving YaeL
and another unknown protease (116); the role of TcpH is to protect TcpP from
this degradation. In the latter case, it is unknown how the tcpA promoter autoregulatory loop that continues ToxT production is broken. In this report, we
present data that suggest proteolysis of ToxT protein is the major factor
responsible for breaking this auto-regulatory loop. ToxT proteolysis occurs when
V. cholerae is grown in vitro at pH 8.5 and 37ºC, a growth condition that is known
to repress virulence production. These are the same growth conditions under
which TcpP is proteolyzed. These results indicate that rapid shutdown of
virulence prior to escape of V. cholerae from the human host back into the
aquatic environment may be mediated by directed proteolysis of both TcpP and
ToxT.
MATERIALS AND METHODS
Bacterial strains, plasmids, culture conditions and reagents. All
bacterial strains and plasmids are listed in Table 1. Strains are maintained at 70˚C in LB media containing 20% glycerol. The strains were grown overnight at
37˚C in LB medium with a starting pH of 8.5 and then were sub-cultured using a
1:40 dilution into either LB at starting pH 6.5 and 30ºC (virulence inducing
conditions) or LB at starting pH 8.5 and 37ºC (virulence repressing conditions).
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For the experiments shifting from inducing to repressing growth conditions, cells
were harvested by centrifugation after 3 hours growth under inducing conditions
and cell pellets were re-suspended into the same volume of fresh LB at either pH
8.5 or pH 6.5 and continued to be cultured at the corresponding temperature
(37˚C or 30˚C). Antibiotics were used at the following final concentrations unless
otherwise

stated:

streptomycin

100

µg/ml;

ampicillin

100

µg/ml;

and

chloramphenicol 5 µg/ml. To induce protein expression, a final concentration of
0.2% arabinose was used to induce pBAD33 vector derivatives while a final
concentration of 1mM of isopropyl-β-D-thiogalactopyranoside (IPTG) was used to
induce pMAL-c2e vector derivatives. To deplete cellular ATP, cells were treated
with a combination of 10 mM of α-methylglucoside and 20 mM of sodium azide
as previously described (86).
β-Galactosidase assay. After the cells were grown under the indicated
time and growth conditions, β-galactosidase activity was measured and
expressed in Miller units as previously described (122).
Plasmid and strain construction. The tcpA promoter deletion strains
were constructed as previously described (197). Briefly, 500-bp segments on
either side of the tcpA promoter were amplified by nested recombinate PCR
method and cloned into suicide vector pKAS32 using KpnI and SacI restriction
sites. The resulted plasmid was transformed into E. coli SM10(λpir), and moved
into both V. cholerae strains O395 and JW 611 by filter conjugation. Arabinoseinducible toxT plasmids which has either N-terminal or C-terminal polyhistidine
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tag was constructed by amplifying the toxT gene from V. cholerae O395 genomic
DNA and cloning it into pBAD33 (58) using XbaI and PstI restriction sites For Nterminal His tagged ToxT, the forward primer BP 81 (5'-GATCTCTAGATTTAGG
ATACATTTTTATGCATCATCATCATCATCATATGATTGGGAAAAAATCTTTTCA
AACTAATG-3') and the reverse primer BP 193 (5’-GATCCTGCAGTTATTTTTCT
GCAACTCCTGTCAAC-3) is used. For C-terminal His tagged, the forward primer
BP 22 (5’-GCTCTAGATTTAGGATACATTTTTATGATTGGGAAAAAATCTTTTCA
AAC-3') and the reverse prime BP 195 (5’-GATCCTGCAGTTAATGATGATGATG
ATGATGTTTTTCTGCAACTCCTGTC-3’) were used. IPTG inducible plasmids
that contain translational fusion of MBP with ToxT that bears his tag at the Cterminal and its N-terminal truncation derivatives using the reverse primer BP
195 and the following forward primers; for full length of ToxT1-276, BP 171 (5’- GA
CAAGGTACCGATGATTGGGAAAAAATCTTTTCAAAC-3’), for ToxT101-276, BP
174

(5’-

GACAAGGTACCGGATCTCATGATAAGGAATTTATATAG-3’),

for

ToxT110-276, BP 185 (5’- GACAAGGTACCGGAAAATAAAGATCTATTACTTTGG3’), for ToxT115-276, BP 186 (5’- GACAAGGTACCGTTACTTTGGAATTGTGAACA
TAATG-3’), for ToxT120-276, BP 187 (5’-GACAAGGTACCGGAACATAATGATATA
GCTGTCCTTTC-3’), for ToxT130-276 BP 188 (5’ GACAAGGTACCGGTGGTAAAT
GGTTTCAGAG-3’), for ToxT151-276, BP 175 (5’- GACAAGGTACCGTTCTTCTCG
AAAGTAGAAAAAAAATATAAC-3’). The PCR products were cloned into pMALc2e using KpnI and PstI restriction sites.
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RNA isolation and qRT-PCR. Cell pellets from different strains were
harvested by centrifugation after 3 hours growth under virulence inducing
conditions. RNA was isolated using Trizol reagent (Invitrogen) according to the
manufacturer's protocol. Total RNA was subjected to DNase I digestion for 1 hr at
37°C to eliminate any DNA contamination. RNA was recovered by ethanol
precipitation and re-suspended in RNase-free water. The RNA concentration was
adjusted to 1 µg/µl based on A260 measurement. To monitor the level of toxT
mRNA, 1 µg of total RNA was subjected to one-step SYBR Green quantitative
RT-PCR using the manufacturer’s protocol (Invitrogen). Specific primers for the
toxT gene were used. The forward BP 105 primer is (5’-TGGGCAGATATTTGTG
GTGA-3’) and the reverse BP 106 primer is (5’- AAACGCTAGCAAACCCAGAC3’). The level of toxT mRNA in each sample was normalized to the level of rpoB
mRNA using the forward BP 100 primer (5’- ATCGAGCGTAACGTCGCGGTTGA
C-3’) and the reverse BP 101 primer (5’- AGTCAGGTTGTAGATGTCGATACC3’). The data represent an average of three independent experiments ± standard
deviation (S.D.) Statistical significance of lower levels of toxT mRNA in the tcpA
promoter deletion was determined by student’s t-test with p value of 0.0101.
Protein analysis and purification. Aliquots of cells harvested at different
time points during growth were normalized unless otherwise stated based on the
optical density at 600 nm and re-suspended in 30 µl water and 10 µl of 4x protein
buffer (246 mM Tris-HCl, 8% sodium dodecyl sulfate, 2.8 M 2-mercaptoethanol,
40% glycerol, 0.4% bromophenol blue). The samples were boiled for 5 min and

71

subjected

to

12%

or

15%

sodium

dodecyl

sulfate-polyacrylamide gel

electrophoresis (SDS-PAGE). The gel was blotted on nitrocellulose paper as
previously described (3) and probed with a 1:3000 dilution of rabbit polyclonal
anti-ToxT serum or 1:5000 dilution of mouse anti-His tag monoclonal antibody
(Millipore). As an internal loading control, the primary mouse anti-elongation
factor alpha 1 (anti-EF-α1) was used at a dilution of 1:3000 (Millipore). Goat antirabbit or anti-mouse immunoglobulin antibodies conjugated to either alkaline
phosphatase (AP) or Horseradish peroxidase (HRP) were used at a dilution of
1:5000 (Southern Biotech). After washing the blots, they were developed using
the corresponding substrate. For AP, immuno-BCIP (5-bromo-4-chloro-3indolylphosphate)—nitroblue tetrazolium was used (Invitrogen). For HRP,
western lightning chemiluminescence substrate (PerkinElmer) was used and the
blots were visualized using Autoradiography X-ray Film.
To purify ToxT fragments, C-terminal His tagged ToxT was overexpressed
for 3 hours under virulence repressing conditions. Bacteria were collected by
centrifugation and re-suspended into buffer A (50 mM sodium phosphate, 300
mM NaCl, 10 mM Imidazole, and 8M Urea at pH 8.0). The cells were lysed by
French press at 1200 psi. Cell debris was removed by centrifugation and the
clear cell extract was incubated overnight with nickel coated beads (Bio-Rad).
The beads were washed 4 times for a total of 40 minutes with buffer A and
collected after each wash by brief centrifugation. The His-tagged protein
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fragments were eluted using 2 ml of elution buffer B (50 mM sodium phosphate,
300 mM NaCl, 250 mM Imidazole, and 8M Urea at pH 8.0).
RESULTS
Monitor the expression and activity of ToxT protein under different
conditions. In classical biotype V. cholerae, maximal virulence induction in vitro
is induced by growing the bacteria at 30º C in LB at starting pH 6.5 (125). These
growth conditions were termed ToxR-inducing conditions due to the significant
role of the ToxR in virulence induction; however, these conditions do not
significantly affect ToxR activity. Instead, these conditions permit production of
TcpP, which acts together with ToxR to activate toxT expression (94, 96, 100,
160), and we will refer to them as virulence inducing conditions. Minimal
virulence induction results when the cells are cultured at 37º C in LB at beginning
pH 8.5 (125), which we will refer to as virulence repressing conditions. Under
virulence inducing conditions, both ToxR and TcpP initiate the activation of toxT
from the toxT promoter. Once ToxT protein is made, it amplifies itself by
activating transcription of the large tcp operon, which contains genes encoding
TCP components and the toxT gene (197). Virulence induction is minimal under
the high pH and temperature virulence repressing conditions, likely due to the
absence of significant TcpP levels, and thus low ToxT levels, under these
conditions. However, there is basal toxT transcription that should result in some
ToxT expression, which could then ostensibly activate tcpA and produce more
ToxT. Overexpression of tcpPH from a constitutive promoter in El Tor V. cholerae
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under virulence repressing conditions results in an increase in CT expression but
the amount of CT produced is still minimal when compared to CT production
under inducing conditions (129), suggesting that ToxT activity is low under these
conditions even when its production is induced by TcpP.
To better understand the regulation of ToxT, a time course experiment
was conducted to monitor the accumulation of ToxT protein by western analysis
and its activity in terms of tcpA activation under both ToxT-inducing and
repressing conditions. tcpA activation was monitored using a chromosomal tcpAlacZ fusion present at the endogenous lacZ locus. The data in Fig. 12A show that
maximal ToxT activity occurs when culturing under virulence inducing conditions
but minimal activity results when culturing under virulence repressing conditions.
Consistent with the observed ToxT activity, ToxT protein (Fig. 12B) was detected
in the bacteria as early as two hours and continually present in the cells up to at
least four hours after subculture into inducing conditions. In contrast, ToxT
protein was undetected at any time point after subculture into repressing
conditions. As a positive control, lane 1 shows purified His6-ToxT and as a
negative control, lane 2 shows a ToxT deletion strain, which lacks the
corresponding ToxT band.
Absence of any detected ToxT protein under virulence repressing
conditions can be explained either by the fact that maximal activation of the toxT
promoter is required to overcome the dilution of ToxT that results from bacterial
replication, or ToxT can’t amplify more of itself by activating the tcpA
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autoregulatory loop under repressing conditions. To assess whether toxT
transcription via the autoregulatory loop occurs under virulence repressing
conditions, we utilized a derivative of classical V. cholerae strain O395 carrying a
chromosomal toxT-lacZ fusion. This strain does not produce functional ToxT
because the lacZ gene is inserted into toxT gene at the HindIII restriction
endonuclease site (65), but transcription into toxT can be monitored by β–
galactosidase assay.
First we assessed the contribution of the tcpA autoregulatory loop under
virulence inducing conditions but in the absence of ToxT. Approximately 300
Miller units of β-galactosidase were produced; this total is the combined
production from both the toxT and tcpA promoters. However, if functional ToxT
was expressed in-trans from a pBAD-toxT plasmid, a three-fold increase in βgalactosidase production to about 800 Miller units was observed (Fig. 13A).
These results suggest that this increase in β-galactosidase production is due to
activation of the tcpA promoter autoregulatory loop by ToxT. Deletion of the tcpA
promoter in this strain prevents the increase in β-galactosidase production
induced by ToxT in-trans, which confirms that autoregulation occurs by activating
the tcpA promoter.
When grown under virulence repressing conditions, the V. cholerae toxTlacZ parent strain produced about 10 Miller units of β-galactosidase, but when
ToxT is applied in trans there is more than a sixty-fold increase in lacZ
production. These results suggest that ToxT is highly active under virulence
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repressing conditions, at least when is it expressed at a high level in trans. The
observed increase in β-galactosidase is a result of the autoregulatory loop of
activation, as parallel experiments in the strain having a deletion of the tcpA
promoters showed no increase in β-galactosidase production despite applying
ToxT in-trans. To more directly measure how much the autoregulatory loop
contributes to the level of toxT mRNA, we performed qRT-PCR to compare the
levels of toxT mRNA in the wild type V. cholerae strain and the tcpA promoter
deletion strain. Deleting the tcpA promoter causes a 2 fold reduction in toxT
mRNA (Fig. 13B). Collectively, these results confirm that the ToxT positive
autoregulatory loop functions through activation of the tcpA promoter under both
virulence inducing and repressing conditions, and contributes to toxT expression.
The above results confirm that ToxT is active when over-produced under
virulence repressing conditions and that ToxT is produced via activation of the
tcpA promoter autoregulatory loop. The next question we asked was whether
ToxT protein produced at natural levels could amplify itself as part of an
autoregulatory loop under repressing conditions. To circumvent the problem that
the initial activation of the toxT promoter by ToxR and TcpP is required for ToxT
production, we cultured the bacteria first under virulence inducing conditions to
induce ToxT production, and then the bacteria were harvested by centrifugation
and resuspended in an equal volume of either fresh inducing medium or fresh
repressing medium. This ensured that there was no dilution of the culture. A
sample from each set of conditions was taken every hour and ToxT protein was
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monitored by western analysis. Fig 14A shows that in primary culture under
inducing conditions, ToxT is present in the cells (Lane 2). However, after shifting
the bacteria into repressing conditions, ToxT protein disappeared after one hour
(Lanes 6, 7, and 8). In contrast, when the cells were resuspended into inducing
media, ToxT protein was continuously detected in the cells (Lane 3, 4 and 5). It is
important to note that the dilution factor that arises from cell division is controlled
by collecting the same volume of cultured media over time. This is apparent in
the internal loading control as the amount of control protein increased over time.
To determine an earlier time point for the fate of ToxT protein after shifting the
culture from inducing to repressing conditions, samples were taken at 0, 15, 30,
60, and 90 minutes and western analysis was performed. The results in Fig. 14B
show that the level of ToxT protein declined after 15 minutes and became
completely undetectable after one hour of incubation. These results suggest that
pre-existing ToxT protein is degraded under virulence-repressing conditions and
this could prevent ToxT auto-amplification under these conditions.
Proteolysis of ToxT requires protein synthesis and ATP. Most of the
cytoplasmic degradation in prokaryotes requires energy (55). V. cholerae
possess at least five different ATP-dependent protease systems (ClpXP, ClpAP,
Lon, HslUV, and HflB) and expression of some of these systems increases in
response to high temperatures as their promoter regions contain a heat shock
σ32 factor binding site (163). To test whether ToxT degradation under virulencerepressing conditions requires protein synthesis to induce a specific protease
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and/or if proteolysis occurs through an ATP-dependent mechanism, two methods
were utilized. We either stopped further protein synthesis by adding high
amounts of chloramphenicol (200 µg/m/) to the bacteria, or we depleted the
bacteria of ATP by adding a combination of sodium azide and non-metabolized
glucose (α-methylglucoside) prior to shifting into repressing conditions; after both
these treatments ToxT accumulation was monitored by western blot. This ATP
depletion method was chosen because it has been shown to rapidly lower ATP
concentration in the cells within ten minutes (86). Treatment of the cells with
chloramphenicol or ATP depletion prior to shifting to repressing growth conditions
prevents ToxT degradation (Fig. 15, lanes 5 and 6). However, depleting the cells
of ATP causes a smaller ToxT band to appear (Fig. 15, lane 5). These results
suggest that ToxT degradation might occur in a sequential manner with at least
two different proteases. ToxT could be initially cleaved by a protease that is less
sensitive to ATP depletion but is induced in response to temperature and pH, and
then further ToxT degradation occurs in an ATP-dependent proteolysis.
ToxT degradation analysis. Because ToxT protein is not detected under
normal growth conditions but produces a smaller protein band when ATP is
depleted from the cells after shifting into repressing conditions, we hypothesized
that overexpression of ToxT under repressing conditions could lead to the
production of ToxT degradation fragments that can be detected by western
analysis. To test this possibility, we overexpressed ToxT protein that carries a
polyhistidine tag at either the N-terminal or the C-terminal end. When His-tagged
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ToxT was over-expressed under virulence repressing conditions, a major smaller
band was reproducibly detected in the cell lysate in addition to full length Histagged ToxT (Fig. 16). Interestingly, the size of this smaller band differed
between the N-terminally and C-terminally tagged ToxT constructs. N-terminally
His-tagged ToxT produced a predominant band smaller than 17kDa. However,
C-terminally His tagged ToxT construct produced a predominant band smaller
than 23kDa but bigger than the 17kDa marker band. These data suggest that
ToxT is initially cleaved at one primary site and then subjected to further
degradation. To confirm that the smaller bands that were detected by western
blotting are part of ToxT, we purified the predominant band that arises from the
C-terminal His tagged ToxT on a nickel column, subjected it to SDS-PAGE, and
then subjected a tryptic digest of the excised band to mass spectroscopy
analysis. The peptide mass spectroscopy fingerprinting from the fragment band
successfully identified multiple peaks corresponding to the C-terminal domain of
ToxT protein. These data confirmed proteolytic cleavage of ToxT under
virulence-repressing conditions.
We attempted to identify the protease that is responsible for ToxT
degradation by both screening a transposon library for mutants that fail to
degrade ToxT and by directly obtaining in-frame deletions of specific cytoplasmic
proteases and assessing whether the deletion prevented ToxT proteolysis under
virulence repressing conditions. However, these methods did not identify any
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individual protease responsible for ToxT degradation. This could be due to the
possibility that more than one protease is capable of degrading ToxT.
Next we determined whether the protease(s) that degrade ToxT are
conserved between the classical and El Tor V. cholerae biotypes and/or other
gram negative bacteria. We assessed whether ToxT degradation occurs in the El
Tor biotype of V. cholerae and in E. coli when His-tagged ToxT is over-expressed
from a plasmid. Overexpression of C-terminally His tagged ToxT protein both in
the El Tor biotype of V. cholerae and in E. coli K12 under virulence repressing
growth conditions resulted in detection of the same small fragments that arise
from ToxT degradation in classical V. cholerae (Fig. 17A and B). Overexpression
of C-terminally His tagged ToxT protein in classical V. cholerae and E. coli K12
under virulence inducing growth conditions resulted in minimal ToxT degradation
(Fig. 18B) when compared to the amount of ToxT proteolysis under repressing
conditions. However, some degradation fragments were detected in E. coli when
cultured under inducing conditions. These results suggest that maximal ToxT
degradation occurs under virulence repressing growth conditions and minimal
degradation occurs under virulence inducing conditions in both V. cholerae
biotypes and even in E. coli.
Identification of the cleavage site(s) within ToxT. To better understand
the sequential degradation of ToxT, we attempted to identify the cleavage site(s)
within ToxT. Several attempts were made to obtain N-terminal sequence
information from the fragments that arise from the C-terminally His tagged ToxT
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degradation. However, these fragments were blocked for Edman degradation
chemistry. As an alternative we sought to map the domain within ToxT that is
recognized by the protease and gives rise to the predominant band that is
detected from the C-terminally His tagged ToxT construct. Translational fusions
of maltose binding protein (MBP) with wild type ToxT-His6 or various N-terminal
ToxT-His6 truncations were constructed, and these proteins were over-expressed
under virulence repressing conditions such that the degradation intermediate
could be detected. Truncation of the first 110, 115, 120,130, and 150 amino acids
abolishes detection of the predominant band that migrates just below the 23kDa
maker band (Fig. 18, lanes 5-9). However, this band was produced by full length
ToxT or ToxT lacking the first 100 amino acids (Fig. 18, lanes 3 and 4). These
results suggest that the region between amino acids 100 and 110 plays a role in
ToxT proteolysis. It is significant to note that this region of ToxT has been shown
to be important for its function. Alanine substitute mutations in amino acids 102,
103, 105, and 106 causes increase in ToxT activity (30). Increasing the activity of
ToxT could be due to increase in stability of ToxT.
DISCUSSION
V. cholerae uses a coordinate regulatory cascade to induce its virulence
determinants (117). While ToxT protein is the primary transcriptional activator
that directly activates expression of major virulence factors including CT and TCP
(75, 190-192, 198), ToxT expression is controlled by ToxR/S and TcpP/H as well
as the positive auto-regulatory mechanism mediated through activation of tcpA
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transcription (39, 65, 67, 100, 197). The current model for the virulence
regulatory circuit is that ToxR and TcpP initiate toxT expression from the toxT
promoter. Once ToxT is made, it maintains its expression through the autoregulatory mechanism by activating the tcpA promoter. Evidence of virulence
down-regulation during the late stage of infection, prior to escaping the host, has
been observed (101, 121, 132). However the mechanism of this down-regulation
is not understood. To turn off virulence expression, toxT expression must be
stopped and this can be achieved by terminating activation of both the toxT and
the tcpA promoters. Recent studies have shown that the level of TcpP is
negatively controlled at multiple levels through promoter repression and protein
degradation (8, 96, 116). This complex regulation might account for shutting off
transcription from the toxT promoter. However, the mechanism for turning off the
tcpA promoter is unknown, and here we present evidence for ToxT proteolysis
when the bacteria are grown under conditions that do not favor virulence
production. Maximal ToxT degradation occurs when the cells are grown under
classical virulence-repressing conditions, whereas minimal or no degradation
occurs when bacteria are grown under virulence-inducing conditions. Further
analysis suggests that the unstructured motif located between ToxT amino acids
100-110 is required for this degradation. ToxT proteolysis likely accounts for the
shutting down of the autoregulatory loop as the bacteria prepare to escape from
the human host and resume their environmental lifestyle.
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There are few examples in the literature of proteolysis controlling the level
and activity of transcriptional regulators in bacteria. It is widely accepted that the
concentrations of these regulators are controlled by their rate of synthesis and
their concentration is decreased due to repeated cell division. However, it has
been shown that lambda CII, lambda CI repressor and LexA repressor proteins
are controlled by proteolytic degradation (56, 109, 147). The CII protein is a
positive regulator for lysogen formation and is cleaved by the ATP-dependent
Lon protease (56). Both lambda and lexA repressors that normally prevent gene
transcription are also autocleaved in an ATP-dependent manner when targeted
by RecA, and so their repression is relieved (109, 187). Further analysis revealed
that the proteolytic degradation of these repressors results in production of two
stable smaller fragments (109, 147). Interstingly, a similar circumstance occur in
regard to ToxT degradation. Proteolytic cleavage of ToxT also produces smaller
fragments with one predominant fragment that is approximately half the size of
ToxT. Proteolytic cleavage of ToxT into fragments should inactivate pre-existing
ToxT as it loses specific motifs that are required for its activity (30).
Depletion of cellular ATP prior to culturing the cells under high pH and
temperature was able to rescue ToxT from degradation. However, a band
smaller than full length ToxT was resolved on SDS-PAGE. This band could result
from cleavage of ToxT protein to produce a slightly smaller polypeptide in a step
that is less sensitive to ATP depletion, and further ToxT degedation is inhibited
by ATP depletion as it occurs in ATP-dependent manner. V. cholerae encodes at
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least three different cytoplasmic ATP-dependent proteases (ClpP, Lon, and
HslV). Thus, we suspected that one of these systems is responsible for ToxT
degradation. However, individual in-frame deletions of clpP, lon, or hslV did not
prevent ToxT degradation. Additionally, inactivation of the recA gene, which
prevents proteolysis of Lambda and LexA repressors (109, 187), did not prevent
proteolysis of ToxT. The degradation fragments that resulted from ToxT
degradation in wild type V. cholerae strain were still detected by western analysis
in recA, lexA, clpP, lon, and hslV mutant strains of V. cholerae (data not shown).
These results suggest that these proteases individually are not required for ToxT
degradation and additional proteases might be able to cleave ToxT. It is worth
noting that deletion of the lon gene from V. cholerae does not result in production
of mucoid colony morphology as it is in E. coli. Searching the V. cholerae
genome revealed additional proteases that are related to the Lon protease.
These or other proteases could possibly substitute for any defective Lon function
and prevent the mucoid phenotype and perhaps ToxT degradation.
Degradation of ToxT is enhanced by increasing temperature. Maximum
ToxT proteolysis occurs when culturing the bacteria in LB with high pH and
temperature. In contrast, minimal degradation occurs when culturing the bacteria
in LB with a lower starting pH and temperature. Further analysis suggests that
the temperature, rather than pH, is the major environmental factor that enhances
ToxT degradation (data is not shown). In general, increased temperature leads to
increased expression and activity of several cytoplasmic protease systems. V.
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cholerae also responds to increased temperature with increased expression of
several proteases and chaperones (163). Additionally, clpB1 and clpB2, which
function to dissociate inactive protein aggregates, are differentially induced in
vivo (inside rabbit intestine) and clpB1 expression increases in response to
higher temperature and pH (130).
Treatment of V. cholerae with chloramphenicol to stop protein synthesis
rescues ToxT degradation. These results suggest that the protease(s) that
degrade ToxT require protein synthesis to function. We further tested whether
any of the above proteases induced at higher temperature are responsible for
ToxT degradation. However, none of the individual mutants prevented ToxT
degradation. Again, a possible explanation is that more than one protease can
degrade ToxT and inactivating one protease at the time might not be sufficient to
prevent ToxT degradation.
The unstructured region of ToxT plays a role in controlling ToxT
expression and activity. Protein fusions of MBP with different parts of ToxT
suggested that the motif located between amino acids 100-110 is important for
ToxT degradation as this region is required to produce the predominant
degradation fragment of ToxT. The recently solved ToxT crystal structure
revealed the 100-110 region of ToxT remained unstructured under the conditions
that were used (111). Unstructured regions of proteins commonly serve as
initiation sites for efficient degradation by the mammalian proteasome (140). In
bacteria these unstructured regions of proteins are less common, but a recent
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study showed that the unstructured motif of the bacterial Pub (prokaryotic
ubiquitin-like) protein is required for its degradation (107). These results may
suggest that bacteria could recognize these unstructured regions of protein to
initiate their degradation. Furthermore, mutational analysis by alanine substitution
in this region enhances ToxT function. Changing amino acids at positions 103,
105, or 106 causes more than a 300% increase in ToxT activity when compared
to wild type ToxT when measured in terms of ctxA-lacz expression (30). Amino
acid substitutions in this region could result in a conformational change in this
motif to stabilize and/or enhance the activity of ToxT.
In summary, we have demonstrated that the ToxT protein is regulated by
proteolysis. The degradation of ToxT maximally occurs under conditions that do
not favor virulence induction while it minimally occurs under conditions that do
favor virulence induction. Furthermore, the disordered domain that extends
between amino acids 100 and 110 appears to play a role in ToxT degradation.
ToxT proteolysis may suggest a model for terminating V. cholerae virulence gene
expression during the course of infection, with both ToxT and TcpP undergoing
proteolysis prior to escape from the host.
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FIG. 12. ToxT protein levels and activity under virulence inducing and repressing
conditions. (A) ToxT activity was measured by tcpA-lacZ fusion expression. Open
bars, culturing under virulence repressing conditions. Grey bars, culturing under
virulence inducing conditions. (B) Time course monitoring ToxT protein
accumulation under inducing and repressing conditions. ToxT protein was
detected using anti-ToxT antibody. For protein loading control; mouse anti-EF-α1
(elongation factor- α1) was used.
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FIG. 13. Transcriptional analysis of the ToxT autoregulatory loop. (A) βgalactosidase production from the chromosomal toxT-lacZ fusion strain. Under
inducing conditions, production of β-galactosidase occurs both through activation
of the toxT promoter and via the autoregulatory loop by activation of the tcpA
promoter (dark grey bars). Under repressing conditions, production of βgalactosidase occurs only through the autoregulatory loop by activation of the
tcpA promoter (dark grey bars). In the absence of ToxT (white bars) or deletion of
the tcpA promoter (light grey bars), production of β-galactosidase occurs only
through the toxT promoter activation. (B) Contribution of the autoregulatory loop
to the level of toxT mRNA. White bar is the tcpA promoter deletion strain. Grey
bar is wild type O395 strain. *Significant difference in toxT mRNA level was
determined by student’s t-test with a p Value of < 0.02.
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FIG. 14. The fate of ToxT protein when shifting the cells from inducing to
repressing conditions. (A) ToxT was undetected after one hour post shifting from
inducing to repressing growth conditions. (B) Earlier time points show the loss of
ToxT protein starts within 15 minutes post shifting and ToxT was undetected after
one hour. Protein loading control shows an increasing in the amount of control
protein over time. Arrows indicate ToxT protein band.
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FIG. 15. ToxT fate in the absence of protein synthesis and cellular ATP. Primary
cultures were grown under inducing conditions to produce ToxT (lane 2). Prior to
shifting into repressing conditions, cells were either not treated (lane 4), treated
with α-methylglucoside and sodium azide to deplete cellular ATP (lane 5), or
treated with chloramphenicol to inhibit protein synthesis (lane 6). ToxT protein
was monitored by western analysis using anti-ToxT antibody. Purified His6-ToxT
was used as a positive control, ∆toxT and ∆toxR strain backgrounds served as
negative controls, and Anti-EF-α1 was used for protein loading control.
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FIG. 16. Proteolytic cleavage of ToxT protein. N-terminal and C-terminal Histagged ToxT was overexpressed while the cells were grown at 37°C in LB with
starting pH 8.5 (virulence repressing conditions). Protein samples were run on
15% SDS-PAGE and His-tagged ToxT and its cleavage fragments were detected
with anti-polyhistidine monoclonal antibody. Solid arrows indicate the
predominant ToxT fragments, whereas light arrows indicate full length and the
minor ToxT degradation fragments. M for protein marker ladder with the
correspond sizes.
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FIG. 17. ToxT degradation in both V .cholerae biotypes and E. coli. Both the
classical and El Tor biotypes of V. cholerae (A) as well as E. coli K12 (B) can
degrade ToxT when cultured under high pH and temperature. (B) ToxT
degradation was observed when V. cholerae or E. coli were grown in either LB at
pH 8.5 and 37°C or in LB at pH 6.5 and 30°C. Full lengh ToxT and the fragments
that resulted from the C-terminal His-tagged protein degradation were detected
with anti-His6 monoclonal antibody.
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FIG. 18. ToxT motif located between amino acids 100-110 is required for ToxT
degredation. When grown under virulence repressing conditions, overexpression
of the translational MBP-ToxT-His6 fusion produces a predominant degradation
fragment just below the 23 kDa protein marker band (arrow) in addition to full
length protein construct (lane 3) similar to the ToxT-His6 control (lane 2). Nterminal truncation of the first 100 amino acids did not interfere with production of
the degradation fragment (lane 4). However, truncation of 110 amino acids or
more prevents production of the degradation fragment. Full length ToxT and the
degradation protein fragment were detected with anti-His6 antibody.
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Strain or Plasmid
Strain
JW 419
JW 75
JW 9
JW 513
JW 150
JW 199
JW 690
JW 611
JW 714
JW 919
JW 922
JW 672
JW 673
JW 808
JW 812
JW 928
JW 895
JW 811
JW 1076
JW 1077
JW 1078
JW 1120
JW 1121
JW 1122
JW 1123
Expression Plasmids
pBAD33
pJW 181
pJW 342
pJW 347
pMAL-c-2e
pJW 412
pJW 413
pJW 429
pJW 430
pJW 431
pJW 432
pJW 414

Discriptions

Reference or Source

E.coli K12
E.coli SM10λpir
V.cholerae classical biotype
O395
V.cholerae El Tor biotype
E7946
O395∆toxT
O395∆toxR
O395tcpA-lacZ
O395toxT-lacZ
JW 150tcpA-lacZ
JW 611∆PtcpA
JW 690∆PtcpA
JW 611 + pBAD33
JW 611 + pJW 181
JW 714 + pJW 342
JW 714 + pJW 347
JW 919 + pJW 181
JW 513 + pJW 342
JW 419 + pJW 342
JW 714 + pJW 412
JW 714 + pJW 413
JW 714 + pJW 414
JW 714 + pJW 429
JW 714 + pJW 430
JW 714 + pJW 431
JW 714 + pJW 432

Lab collections
(162)
Lab collections

Arabinose-inducible plasmid
pBAD-toxT
pBAD-toxT-his6
pBAD-his6-toxT
IPTG-inducible plasmid
pMal- ToxT1-276-His6
pMal- ToxT101-276-His6
pMal- ToxT110-276-His6
pMal- ToxT115-276-His6
pMal- ToxT120-276-His6
pMal- ToxT130-276-His6
pMal- ToxT151-276-His6

(58)
(3)
This work
This work
New England Biolabs
This work
This work
This work
This work
This work
This work
This work

Lab collections
(25)
(100)
(3)
(65)
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work
This work

Table 1. List of strains and expression plasmids used in this work.
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CHAPTER THREE
Genetic Screening for Bacterial Mutants in Liquid Growth Media by
Fluorescence-Activated Cell Sorting
ABSTRACT
Many bacterial pathogens have defined in vitro virulence inducing
conditions in liquid media which lead to production of virulence factors important
during an infection. Identifying mutants that no longer respond to virulence
inducing conditions will increase our understanding of bacterial pathogenesis.
However, traditional genetic screens require growth on solid media. Bacteria in a
single colony are in every phase of the growth curve, which complicates the
analysis and make screens for growth phase-specific mutants problematic. Here,
we utilize fluorescence-activated cell sorting in conjunction with random
transposon mutagenesis to isolate bacteria grown in liquid media that are
defective in virulence activation. This method permits analysis of an entire
bacterial population in real time and selection of individual bacterial mutants with
the desired gene expression profile at any time point after induction. We have
used this method to identify Vibrio cholerae mutants defective in virulence
induction.
INTRODUCTION
A common theme among bacterial pathogens is the response to host or
environmental cues during an infection, followed by modulation of virulence gene
expression. Isolating bacterial mutants that no longer respond to these cues
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allows us to identify genes involved in virulence regulation and increases our
understanding of how environmental cues contribute to virulence. Screening for
regulatory mutants utilizing lacZ fusion technology has been successfully applied
to a wide range of biological processes (157). In this method, transcriptional
fusions are constructed between a promoter of interest and lacZ, which encodes
β-galactosidase. By screening for bacteria with altered β-galactosidase
production, mutations of interest can be isolated. However, this method requires
culturing the bacteria on solid media to identify blue and white colonies using XGal. Within a single colony, bacteria in each stage of the growth curve are
present, which can make identification of some mutants difficult. The lengthy
growth period required to form a colony may also result in the slow accumulation
of β-galactosidase, resulting in failure to identify mutants of interest.
Many bacterial pathogens have well-defined in vitro conditions that induce
virulence gene expression in liquid media. Developing a screening method to
isolate mutants in liquid media, in which most bacteria are in similar phases of
the growth curve, and which may, in some cases, better mimic the interaction
between the bacteria and the stimuli in vivo (3), would be a major improvement
over traditional genetic screening methods.
Fluorescence-activated cell sorting (FACS) technology has been shown to
be an efficient method to isolate specific bacterial populations (9, 139). FACS
has also been used to isolate intracellular bacteria and bacteria grown during
infections that modulate gene expression (18, 184), and to identify promoters
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induced during infection (183); this method is generally known as differential
fluorescence induction. Here, we utilized FACS technology to screen a bacterial
random transposon mutant library grown in vitro in liquid medium. We used the
gram-negative pathogenic bacterium Vibrio cholerae for our screen as its
virulence inducing and repressing conditions in liquid media are wellcharacterized (50, 125).
V. cholerae is the causative agent of cholera and responds to
environmental factors including pH, temperature, osmolarity, certain amino acids,
bile, and bicarbonate to modulate virulence (57, 82, 125). Classical biotype V.
cholerae virulence gene expression can be controlled simply by altering the
starting pH of LB medium and growth temperature. In LB starting at a low pH (pH
6.5) and lower temperature (30°C) virulence gene expression is fully induced. In
LB starting at a high pH (pH 8.5) and higher temperature (37°C), virulence gene
expression is minimal (50, 125).
We designed a screening method that utilized FACS to identify and select
bacterial mutants having lowered V. cholerae virulence gene transcription under
virulence inducing conditions in liquid media. The V. cholerae strains used in this
screen carry a fusion of the tcpA promoter region, which controls expression of
the toxin-coregulated pilus, a major V. cholerae virulence factor, to the gfp gene
encoding green fluorescent protein (GFP). The GFP produced from these
constructs has a half life of ~20 minutes (18), so the problem of slow
accumulation of GFP over time, leading to false positives, is avoided. The V.
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cholerae mutant library was created using random transposon mutagenesis. This
FACS screening method identified all genes known to positively regulate V.
cholerae virulence gene expression as well as genes that had no previously
known role in virulence gene expression. Similar screens are likely to be very
useful for other bacterial pathogens having defined growth conditions in liquid
media.
MATERIALS AND METHODS
Bacterial Strains, Reagents, and DNA Manipulation. V. cholerae
classical biotype strain O395 was used as the parent strain to generate the
transposon mutant library, an isogenic ∆toxT strain was used as a negative
control, and E. coli SM10 (λpir) was used for conjugation. All strains were
maintained at -70°C in LB medium containing 20% glycerol. Bacteria were grown
in LB medium containing antibiotics at the following concentrations: streptomycin,
100 µg/ml; ampicillin, 100 µg/ml; and kanamycin, 50 µg/ml. The tcpA::gfp fusion
plasmid (pJW316) was constructed by PCR amplifying the tcpA promoter from V.
cholerae O395 genomic DNA and cloned into pMW82 (18) using SphI and XbaI
restriction sites. To construct the chromosomal tcpA-gfp fusion, tcpA::gfp was
amplified by PCR along with 600 bp segments of the lacZ gene and cloned into
the suicide vector pKAS32. The resulting product was moved into the V. cholerae
lacZ locus by filter conjugation as previously described (162).
Transposon Mutagenesis and Identifying Site of Insertion. The suicide
plasmid pFD1, which encodes the Kanamycin resistance Himar1-derived
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transposon and Himar1 transposase, was introduced by filter conjugation into V.
cholerae O395 carrying pJW316. This was done by co-incubating V. cholerae
(recipient strain) and SM10 (λpir) (donor strain) on nitrocellulose filter paper over
an LB plate for 3 hours at 37°C. Cells were then washed into LB media
containing Streptomycin and Ampicillin and 2mM of

isopropyl b–D-1-

thiogalactopyranoside (IPTG) was added to induce the expression of the
transposase. V. cholerae transposon mutants were selected on LB plates
containing streptomycin, ampicillin, and kanamycin. The plates were incubated
for 7 hours at 37°C, which was sufficient for colony formation. Resulting colonies
were pooled and cultured in liquid medium for 3 hours under virulence inducing
(LB at pH 6.5 and 30°C) or repressing conditions (LB at pH 8.5 and 37°C). At
this point the bacteria are in logarithmic growth phase (115) and the V. cholerae
virulence regulon is fully induced (190-192).
Direct sequencing by using genomic DNA was performed to identify the
insertion site of the transposon. Briefly, genomic DNA was isolated from each
mutant using the Wizard Genomic DNA Purification Kit (Promega). The DNA
sequence adjacent to the transposon was obtained by using primers BP 30 (5'ATGCATTTAATACTAGCGACGCC-3')

or

BP

31

(5'-

CGCTCTTGAAGGGAACTATGTTG-3'), which bind near the ends of the
transposon.
Flow Cytometry and FACS. V. cholerae O395 strain lacking gfp was
grown under inducing conditions for 3 hours and used to set the parameter
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channels of the flow cytometer and the cell sorter. The three parameters; forward
scatter (FSC), sideward scatter (SSC) and green fluorescence (515-545 nm),
were set using a logarithmic scale. For flow cytometry analysis, the level of green
fluorescence was measured by using a FACSscan flow cytometer (Becton
Dickinson) and the data were further analyzed with FlowJo analysis software. For
bacterial sorting, low GFP-expressing mutants were sorted using a FACS Diva
(Becton Dickinson) into LB media containing 20% glycerol and stored at -70°C.
Individual colonies were recovered by plating the FACS isolates on LB plates
containing ampicillin, streptomycin and kanamycin.
Statistical analysis. The percentage of GFP-expressing cells was
calculated as the average of three independent experiments ± standard deviation
(S.D.) Statistical significance of the low level of gfp-producing mutants was
determined by student’s t-test with p value <0.0006.
RESULTS
gfp fusion constructs. We constructed strains carrying the tcpA::gfp
fusion on either the bacterial chromosome or on a plasmid. The plasmid-based
construct is a derivative of pMW82 (18) in which the tcpA promoter region from
classical V. cholerae strain O395 has been inserted upstream of gfp to create
pJW316. Wild-type O395 and JW150, an isogenic strain containing a deletion of
toxT, the major virulence activator, were then transformed with pJW316.
Because ToxT activates transcription of all major V. cholerae virulence genes,
including tcpA, we used the tcpA promoter region as a prototypical major
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virulence promoter. Preliminary flow cytometry experiments with these strains
indicated that high GFP levels were produced when bacteria were grown under
virulence inducing conditions (Fig. 19A), whereas very low GFP levels were
produced when bacteria were grown under virulence repressing conditions. GFP
production is ToxT -dependent, as the ∆toxT strain that carries tcpA::gfp did not
express any GFP.
Transposon mutagenesis and FACS screening. V. cholerae O395
carrying tcpA::gfp was subjected to mariner-based transposon mutagenesis. This
method was chosen because it has proven very effective in producing mutant
libraries (148). Approximately 105 mutant colonies were pooled after growth on
LB plates containing proper antibiotic. The mutant pool was also tested for
response to virulence inducing and repressing conditions by measuring GFP
levels. As expected, most of the mutant pool resembled wild type V. cholerae
and produced high GFP levels under inducing conditions and low GFP levels
under repressing conditions (Fig. 19B). To identify mutants with defects in
activation of tcpA expression we grew the mutant pool under virulence inducing
conditions and screened for low GFP-expressing cells by FACS.
Identification of genes that are required for V. cholerae virulence
gene expression. Using the FACS screen/selection described above, we sorted
approximately 3 X105 transposon mutants having low tcpA::gfp expression in
liquid medium from a population of 6 X 108 V. cholerae. Individual mutants were
plated and resulting colonies were re-suspended in liquid medium as before,
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grown for 3 hours under virulence inducing conditions, and retested by flow
cytometry to verify low GFP expression levels in liquid medium under inducing
conditions. One hundred fifty-five mutants were individually tested in this manner
and fifty-three transposon mutants were identified that had reproducibly low GFP
expression; genes carrying the transposon insertion were identified by DNA
sequencing out of the transposon. The genes containing transposon insertions
included known positive virulence regulators aphA, aphB, tcpP, toxR, and toxT
that validate our screening method (Fig. 20). In addition we identified genes
encoding N-acetylmuramoyl-L-alanine amidase (amiB), DNA mismatch repair
protein MutL (mutL) and DNA polymerase II (polB), as previously unknown
positive virulence regulators (Fig. 20).
DISCUSSION
Here we describe a FACS-based screening system for identifying bacterial
mutants with altered virulence gene expression in liquid growth media. Our data
indicate that this screening system works well for V. cholerae, which has welldefined virulence inducing and repressing conditions in liquid media. In addition
to experiments described above that identified mutants with defects in virulence
gene expression under classical virulence inducing conditions, we have
successfully performed screens for mutants that have increased virulence gene
expression under classical virulence repressing growth conditions (B. H. Abuaita
and J. H. Withey, unpublished data). We have also observed altered GFP
expression when either classical or El Tor biotype V. cholerae are grown in the
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presence of two natural effectors, bile and bicarbonate, and have isolated
mutants that do not respond to either of these effectors (B. H. Abuaita and J. H.
Withey, unpublished data). Therefore, this screen should be useful in general for
identifying V. cholerae mutants with alterations in the virulence regulatory
cascade. Our screen successfully identified all known positive virulence
regulators, as well as genes not previously known to be involved in the virulence
cascade. These results strongly validate the methodology of screening for
bacterial mutants by FACS in liquid culture.
In addition to V. cholerae, this screen should prove useful for any bacterial
species with defined growth conditions in liquid medium. Other bacterial
pathogens having well-defined virulence-inducing conditions in liquid media
include

Bacillus

anthracis,

Streptococcus

pyogenes,

Enterohemorrhagic

Escherichia coli, and Citrobacter rodentium, all of which stimulate virulence
induction in response to the presence of CO2/ bicarbonate in liquid media (2, 7,
22, 81, 196). Additionally, Yersinia pestis induces its type-three secretion system
in response to low calcium levels (170), and Bordetella pertussis induces the
BvgAS system when subcultured into media lacking MgSO4 or nicotinic acid (32,
167). These different growth conditions have been designed to maximize
virulence factor production. However, the mechanisms by which these
environmental signals stimulate virulence are not well defined. Isolating bacterial
mutants that no longer respond to these cues using FACS technology will
increase our understanding of how these different systems work. Utilizing FACS
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technology to screen for mutants grown in liquid media allows examination of an
entire bacterial population (or entire mutant library) in real time and provides a
significant advantage over the classical lacZ screens on solid media.
Our screen for V. cholerae mutants with defects in virulence activation
identified not only all the known positive virulence regulators but also amiB, mutL
and polB, three potential positive regulators. Both mutL and polB are involved in
the DNA repair system, while amiB is involved in cell wall hydrolysis (13, 182).
amiB is located adjacent to mutL and in E. coli the mutL promoter region is
located within amiB (182). Because the transposon inserted near the end of
amiB, we suspect that this mutant may have a polar effect on mutL expression.
The DNA repair systems could positively affect virulence induction by
maintaining the integrity of the V. cholerae genome. Both mutL and polB are
involved in DNA repair. One explanation for how mutations to these genes may
affect virulence gene induction is by an increase in secondary mutations.
Secondary mutations could affect known transcriptional activators (AphA, AphB,
TcpP, ToxR, and/or ToxT), or alter DNA binding sites recognized by these
activators. An in-frame mutL deletion strain constructed after identifying mutL in
the FACS screen had the same tcpA expression defects as the mutL transposon
insertion strain and also had a defect in cholera toxin production (data not
shown), confirming that disrupting mutL causes a bona fide defect in virulence.
Further work is being done to understand how the mutL and polB mutations
reduce virulence induction.
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Here, the FACS-based screening method was shown to be effective for
identifying transposon insertions that disrupt virulence activation. However, the
screen can easily be modified for other applications. Isolating transposon
mutants with constitutively active virulence promoters can identify negative
virulence regulators. Another application of this technique could be isolating
mutants based on cell size. Different cell sizes can be distinguished and isolated
by FACS based on forward and sideward scatter profiles. This type of screen
would be useful for further understanding the mechanism by which different
growth conditions lead to different cell sizes, as we have limited knowledge
regarding the regulatory pathways that govern this process.
In summary, we were able to identify and select mutants that did not
induce PtcpA-gfp expression under virulence-inducing growth conditions in liquid
using FACS. Because V. cholerae has well-defined virulence inducing and
repressing conditions in liquid media but ill-defined virulence characteristics on
solid media, this screen has proven very useful to us for many different
applications. Many other bacteria, especially pathogens, also have well-defined
growth conditions in liquid that induce virulence, and thus we believe FACS
genetic screening will prove very useful to many labs.
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FIG. 19. GFP production under inducing and repressing conditions. (A)
Histograms show the level of gfp fluorescence intensity of V. cholerae O395 and
its isogenic ∆toxT strain that carry the tcpA::gfp fusion plasmid and grown under
inducing or repressing conditions. The red histograms represent gfp negative V.
cholerae grown under inducing conditions, the blue histograms represent the
fluorescent bacteria. The percentage of gated cells is the average of three
independent experiments with ±S.D. (B) FACS analysis of a pool of mutants
grown under inducing or repressing conditions. A wide range of gfp expressing
mutants was produced when grown under inducing conditions as most of the
mutants produce high fluorescence while some produced low gfp. Under
repressing conditions, most of the mutants produce low gfp while some produce
intermediate fluorescence levels.
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FIG. 20. Individual transposon insertion mutants exhibit a lower level of tcp::gfp
expression when grown under inducing conditions. The red histograms show
non-fluorescent V. cholerae grown under inducing conditions. The blue
histograms represent gfp fluorescence intensity of different transposon insertion
mutants and parent strain. The percentage of gated cells is an average of three
independent experiments. Statistical significance between each individual mutant
and the parent strains was determined by student’s t-test with P value <0.0006.
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APPENDIX A
The effect of ToxT on swarming motility
Virulence and motility are two processes that are inversely regulated by V.
cholerae. Hyper-swarming motile bacterial strains produce lower levels of TCP
and CT, while non-swarming motile bacteria produce larger amounts of TCP and
CT when compared to the wild type parent strain (49). The mechanism by which
one process regulates the other is not well understood. The two processes
require massive amounts of energy and one explanation is that V. cholerae can’t
perform the two functions at once. Therefore, regulators must somehow activate
one process while repressing the other. The primary virulence activator is ToxT
and a ∆toxT strain is hyper-motile (Table 2). To further analyze the role of ToxT
in the capability of the bacteria to swarm, we overexpressed ToxT in trans from
pBAD-toxT in a ∆toxT strain and assessed the overall swarming motility. Different
strains of V. cholerae were stabbed using a toothpick onto swarming plates (LB
with 0.3% agar) that contain arabinose to induce ToxT expression and
chloramphenicol for plasmid stability. The plates were incubated at 37°C for 16
hours and the swarming diameter for each strain was measured.
Overexpressing ToxT significantly inhibits total motility. ToxT-expressing
strains produce swarming circles of 14 mm in diameter on average, whereas the
control plasmid produces swarming circles 32 mm in diameter on average (Table
2). These results suggest that ToxT can repress or induce gene products that
affect the swarming motility. One mechanism for this is that ToxT directly
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activates the production of the TCP. Over-produced pili could lead to the
formation of microcolonies, which could interfere with flageller rotation and thus
reduce swarming motility. To test this possibility, we overexpressed ToxT in a
∆toxT and ∆PtcpA (tcpA promoter deletion) strain and assessed total swarming
motility. Overexpressing ToxT in this strain still inhibits swarming motility when
compared to a strain that harbors the control plasmid. Double deletion of toxT
and the tcpA promoter strain which harbors pBAD-toxT produced a 15 mm
swarming diameter as apposed to a strain harboring the control plasmid, which
produced 30 mm. These results suggest that the effect of ToxT on
overproduction of TCP can’t account for the effect of ToxT on swarming motility.
To further assess whether functional ToxT is required to reduce swarming
motility, we overexpressed a ToxT mutant that either has a point mutation at
amino acid 52 or a truncation mutant that lost the second helix-turn-helix motif.
These ToxT mutants are defective in activation of a tcpA-lacZ fusion (M. Bellair;
unpublished data). Overexpressing ToxT∆hth mutants in a ∆toxT strain did not
inhibit swarming motility, while an amino acid substitution at position 52
somewhat reduced the swarming motility by an average of 7 mm. These results
suggest that functional ToxT is required for swarming motility inhibition.
In vivo virulence and motility have also been proposed to be inversely
regulated. To assess whether overexpression of ToxT, which interferes with
swarming motility, affects overall colonization of the infant mouse gut, we utilized
two approaches. First, a strain with plasmid-based overexpression of ToxT
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protein was competed with a control parent plasmid strain. Second, a
constitutively ToxT-expressing strain (ToxTC) was constructed and assessed for
its ability to compete with wild type O395 for colonization of the infant mouse
intestine.
The ToxTC strain was constructed by fusing a λ PR promoter to toxT (λ PRtoxT) and inserted into the lacZ locus of V. cholerae. The new strain was
confirmed for its ability to constitutively express ToxT under repressing conditions
when ToxT protein is normally undetected in wild type parent strains (Fig. 21A).
ToxT protein is also functionally active in the ToxTC strain (Fig. 21B). Notably, the
level of ToxT protein and its activity is still at minimum when compared to the
level of ToxT protein produced by the cells that are grown under inducing
conditions (Figs. 21A and B). The difference in ToxT protein is not due to lower
toxT transcripts as real time PCR showed that the level of toxT transcripts are the
same under inducing and repressing conditions (Fig. 21C). These results
suggest that ToxT protein is regulated at a posttranscriptional level and perhaps
by degradation (see Chapter 2 of this dissertation).
To test the ability of ToxTC strains to colonize the infant mouse intestine, a
competitive index was determined. An equal amount of wild type O395 and
ToxTC strains were inoculated intra-gastrically into 4-day old mice. After 16 hours
of incubation at 30ºC, the mice were sacrificed, their intestines were
homogenized, serially diluted with LB and plated on LB plates containing
streptomycin and X-Gal. White colonies (ToxTC, lacZ-), and blue colonies (wild-
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type, lacZ+) were counted after 16 hours of incubation at 30ºC. In vitro control
growth was done in which the combined inocula were plated on LB plates
containing streptomycin and X-Gal and incubated at 30ºC for 16 hours. The
competitive index (CI) was calculated by utilizing the following formula; CI =
(white/blue during infection) / (white/blue in vitro). Data in Fig. 22 show there was
a small defect (about half fold) in the ability of the ToxTC strain to colonize the
infant mouse intestine. Similar results were obtained when ToxT protein was
overexpressed from a plasmid and competed with a strain that harbors the
control plasmid (Fig. 22). Collectively, these results suggest that overexpressing
ToxT might not be deleterious to the cells as V. cholerae has multiple
mechanisms to regulate its level and activity during infection.
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Strain

Genetic Discriptions

Swarming Motility
Diameter (mm)

JW 715

O395∆toxT + pBAD33

32 ± 3

JW 716

O395∆toxT + pBAD-toxT

14 ± 2

JW 927

O395∆∆PtcpAtoxT +
pBAD33

30 ± 3

JW 928

O395∆∆PtcpAtoxT +
pBAD-toxT

15 ± 3

JW 952

O395∆toxT + pBADtoxT∆hth

31 ± 3

JW 953

O395∆toxT + pBADtoxTE52A

23 ± 3

JW 989

O395 + pBAD33

17 ± 2

Table 2. ToxT affects the swarming motility of V. cholerae. Overexpression of
ToxT, ToxT mutation or a control parent plasmid in the indicative strain were
assessed for effects on swarming motility. Swarming motility was measured by
diameter of migration in soft agar.
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FIG. 21.Charecterstics of a strain expressing ToxT constitutively (ToxTC).
Expression of ToxT protein (A) and its activity in terms of cholera toxin production
(B) were measured after wild type O395 or its derivative ToxTC strain were grown
under inducing and repressing conditions. (C) The level of toxT mRNA that is
produced by the two strains when grown under both conditions was determined
by quantitative RT-PCR and normalized to the level of rpoB mRNA. ToxT protein
was detected with anti-ToxT antibody.
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FIG. 22. Competitive indices of V. cholerae strains that overexpress ToxT in the
infant mouse model. The constitutive ToxT expressing strain (O395toxTC) was
competed with wild-type O395 while the plasmid-based ToxT overexpressing
strain (O395 + pBAD-toxT) was competed with O395 + pBAD33. Shaped boxes
represent individual mice.
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Appendix B
Isolating Bacterial Mutants that Affect the Activity of ToxT protein
To identify negative regulators that affect the activity of ToxT, we utilized a
tcp-gfp fusion construct to isolate mutants with elevated ToxT activity when
cultured under virulence repressing conditions. A pool of mutants was cultured
under high pH and temperature, conditions under which wild type bacteria
express a small amount of GFP, and high GFP expressing mutants were
selected. This screen identified phosphoenol carboxykinase (pckA) and isocitrate
dehydrogenase (icd) as potential negative regulators of ToxT activity. When
these mutants were cultured under repressing conditions, they produced higher
amounts of GFP when compared to the wild type strain (Fig. 23). Both pckA and
icd are involved in central metabolism, therefore virulence and central
metabolism could somehow be intertwined.
The second screen was done to isolate mutants that are required for the
ToxT autoregulatory loop. We used the toxT-lacZ reporter strain. This strain does
not produce functional ToxT. However, when ToxT is applied in trans and the
cells are grown at high pH and temperature on plate media (virulence repressing
conditions), β-galactosidase is produced through the autoregulatory loop by
ToxT-dependent activation of the tcpA promoter. A pool of mutants of this parent
strain were grown on LB plates at pH 8.5 containing arabinose, triple antibiotic
(streptomycin, kanamycin, and chloramphenicol), and X-Gal. Arabinose was
added to induce toxT expression while X-Gal was added to monitor β-
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galactosidase activity. White and light blue colonies were picked for further
analysis. All white colonies gave transposon insertions in the toxT gene. This
confirms and validates our screen. Seven out of forty-four light blue colonies
were isolated and lower levels of β-galactosidase were confirmed to be produced
when cultured in liquid media (Fig. 24). The transposon insertions for three of the
seven mutants were determined to be in pntB, varA, and uvrC. The varA gene is
the response regulator that has been shown to activate three small regulatory
RNAs (csrB, csrC, and csrD) implicated in quorum sensing (104) (Fig. 4). In
addition, the varA deletion strain produces lower levels of TCP and CT, and is
attenuated in mice (193). However, the mechanism for how varA negatively
affects virulence is not understood. To further study the effect of VarA, an inframe deletion of V. cholerae varA was constructed. Deletion of the varA gene
produces translucent colony morphology. It is severely attenuated in mice, but
produces the same levels of TCP and CT in vitro when it is compared with the
wild type strain. Future analysis should be conducted to understand the
mechanism of attenuation of the ∆varA strain in vivo. This type of screen should
also be repeated to isolate additional mutants that affect the activity of ToxT
protein.
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FIG. 23. V. cholerae mutants with elevated ToxT activity. Histograms show the
level of gfp fluorescence intensity of V. cholerae O395 and transposon mutant
derived strains that carry the tcpA::gfp fusion plasmid after growth under inducing
or repressing conditions. The red histograms represent gfp negative V. cholerae
grown under inducing conditions, the blue histograms represent the fluorescent
bacteria. Both pckA and icd transposon mutants show elevated tcpA::gfp
expression under repressing conditions.
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FIG. 24. Defective mutants in activation of the autoregulatory loop. Seven
mutants (1, 2, 3, 4, 13, 17, and 24) showed more than three fold reduction in the
ability of ToxT to activate the autoregulatory loop when compared to a wild-type
parent strain. All mutant strains carry the pBAD-toxT plasmid and were grown
under repressing conditions in the presence of 0.2% arabinose. Mutant 20
produced a basal level of β-galactosidase activity.
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CONCLUSION
Vibrio cholerae, which is part of the normal aquatic flora around the world,
uses a complex regulatory cascade to control expression of virulence
determinants that it has acquired though horizontal gene transfer to facilitate
colonization of the human intestine and to cause disease. For the past forty
years, V. cholerae research has led to the discoveries of several regulators that
are involved in the controlling virulence. Most of these studies were focused on
understanding how expression of these regulators is controlled at the
transcription level. However, posttranscriptional regulation of several key
regulators such as TcpP and ToxT has been observed. ToxT protein is the
primary transcriptional regulator that activates most virulence factors of V.
cholerae, including TCP and CT, and can also activate itself through an
autoregulatory loop of activation. The research that is presented in this
dissertation highlights the regulation of ToxT protein after its initial production.
Two effectors with opposite function control the activity of ToxT protein.
Addition of bile or bile components to the culture media reduces the activity of
ToxT whereas addition of bicarbonate enhances ToxT activity. Bile and
bicarbonate are found in the small intestine where V. cholerae colonizes, and
could be the natural effectors or signal molecules that V. cholerae senses to
direct the bacteria into the appropriate niche within the intestine and provide a
specific time for when virulence is induced and repressed. Future work should be
conducted to better understand the mechanism of reduction and enhancement of
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bile and bicarbonate over the activity of ToxT. With this knowledge we would
have a better understanding of how ToxT protein is regulated and design simple
cheap synthetic molecules that inactivate the function of this protein.
ToxT protein is also regulated by proteolysis and this could be the
mechanism for virulence termination. Early studies that monitored the V.
cholerae transcriptome during infection led to the discovery of temporal virulence
regulation. Both TCP and CT expression are induced during the early stages of
infection and are repressed during the late stage of infection.

We have a

relatively good understanding of how virulence is turned on as many studies
have been conducted to elucidate this induction. However, how virulence is
terminated is not known. Virulence induction occurs through coordinate activation
of the ToxR/TcpP/ToxT system in response to a still unknown in vivo signal.
Here, ToxT degradation by proteolysis under certain conditions has been
demonstrated and this could account for virulence repression during the natural
course of infection. Future work that identifies the protease that is responsible for
ToxT degradation would be a major scientific achievement as it would increase
our knowledge and understanding of the mechanism that the bacteria utilize to
control the activity of transcriptional regulators at posttranscriptional levels and
perhaps through proteolysis regulation.
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Vibrio cholera, the causative agent of the severe diarreal illness cholera,
uses a complex array of gene regulation to induce its virulence determinants.
During the early stage of infection, and upon response to unknown signals,
virulence genes are turned on. ToxT protein is the primary virulence gene
transcription activator. Once ToxT is produced, it amplifies its own expression
through an auto-regulatory loop and directly binds and activates expression of
various virulence factors including the toxin-coregulated pilus (TCP) and cholera
toxin (CT). During the late stage of infection, virulence genes are turned off and
the bacteria escape the host to resume their lifestyle in the aquatic environment.
While posttranscriptional regulation of ToxT has been observerd, most studies
were focused on revealing how toxT expression is initiated. Here, the regulation
of ToxT protein at the posttranscriptional level has been explored.

150

In chapter one, experiments are presented that indicate bicarbonate is a
positive effector molecule that enhances ToxT activity. Culturing the bacteria in
the presence of bicarbonate increases the ToxT activity without inreasing the
protein level. Bicarbonate is found in the small intestine where V. cholerae
colonize humans and could be the natural signal that the bacteria sense during
the course of infection to maximally induce its virulence determinents.
In chapter two, the mechanism of virulence down-regulation as V.cholerae
terminates its virulence expression during the late stage of infection preparing to
enter back into the environment is assessed. The data suggest that virulence
expression could terminate through ToxT proteolytic degradation. ToxT
proteolysis was observed when culturing the bacteria at high temperature and
pH, condition that has been found to repress virulence induction. Further analysis
revealed that the unstructured motif which is located between amino acids 100110 of ToxT is important for this degradation.
In the last chapter, a method of utilizing fluorescence-activated cell sorting
(FACS) technology in conjuction with transposon mutagenesis is described. This
method was used to isolate bacterial mutants that produce different gene
expression profiles in response to environmental cues while cultured in vitro in
liquid growth media.This technique should be applicable for isolating bacterial
mutants that respond differently to chemical and physical inducers or repressors
that are present in the liquid growth conditions.
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